CINXE.COM

<!doctype html> <html lang="en"> <head> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <title>Editorial Board Members - Journal of Developing Drugs</title> <meta name="keywords" content="Journal, Developing, Drugs" /> <meta name="description" content="eoed-Editorial Board of Journal of Developing Drugs journal consists a group of prominent personalities with expertise in field who can add value to the existin" /> <meta name="format-detection" content="telephone=no" /> <meta name="google-site-verification" content="NomPTP94YozsgvD3NEFpNqUfY88e0TU0L64zNzZTpd0" /> <meta itemprop="name" content="longdom" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="ROBOTS" content="INDEX,FOLLOW" /> <meta name="googlebot" content="INDEX,FOLLOW" /> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" /> <link rel="canonical" href="https://www.longdom.org/developing-drugs/editorial-board.html" /> <link rel="alternate" href="https://www.longdom.org/developing-drugs/editorial-board.html" hreflang="en-us" /> <script type="application/ld+json"> { "@context": "https://schema.org", "@type": "Organization", "url": "https://www.longdom.org/developing-drugs/editorial-board.html", "logo": "https://www.longdom.org/assets/img/longdom-logo.svg" } </script>  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" /> <link href="/assets/css/longdom.css" rel="stylesheet" /> <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/animate.css/3.7.0/animate.min.css" />  <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.7.1/css/all.css" /> <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css" />  <link href="https://fonts.googleapis.com/css?family=Montserrat:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i|Open+Sans:300,300i,400,400i,600,600i,700,700i,800,800i|Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet" /> <link href="/assets/css/ionicons.min.css" rel="stylesheet" />  <link rel="stylesheet" href="/assets/css/jquery.mCustomScrollbar.min.css" /> <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-select/1.13.2/css/bootstrap-select.min.css" />  <link rel="stylesheet" href="/assets/css/global.css" />  <link rel="stylesheet" href="/assets/css/styles.css" /> <link rel="stylesheet" type="text/css" href="/assets/css/author.css" /> <link rel="icon" href="/assets/img/favicon.png" type="image/gif" /> <link rel="stylesheet" href="/assets/css/coolautosuggest.css" />   <script async src="https://www.googletagmanager.com/gtag/js?id=G-LE7WH45F9C"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-LE7WH45F9C'); </script> <meta property="og:title" content="Longdom Publishing SL | Open Access Journals" /> <meta property="og:site_name" content="Longdom" /> <meta property="og:url" content="https://www.longdom.org/" /> <meta property="og:description" content="Longdom Publishing SL is one of the leading international open access journals publishers, covering clinical, medical, and technology-oriented subjects" /> <meta property="og:type" content="article" /> <meta property="og:image" content="https://www.longdom.org/assets/img/longdom-logo.svg" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@org_longdom" /> <meta name="twitter:title" content="Longdom Publishing SL | Open Access Journals" /> <meta name="twitter:description" content="Longdom Publishing SL is one of the leading international open access journals publishers, covering clinical, medical, and technology-oriented subjects." /> <meta name="twitter:image" content="https://www.longdom.org/assets/img/longdom-logo.svg" />  <script> !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','//connect.facebook.net/en_US/fbevents.js'); fbq('init', '297919997051754'); fbq('track', "PageView"); </script>  </head> <body> <header>  <nav class="navbar navbar-expand-lg navbar-light bg-white shadow-sm deva541"> <div class="container"> <a class="navbar-brand" href="https://www.longdom.org/" title="Longdom Publishing S.L"> <img src="/assets/img/longdom-logo.svg" alt="" height="25"> </a> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="collapse navbar-collapse justify-content-end" id="navbar"> <div class="navbar-nav"> <a class="nav-item nav-link" href="https://www.longdom.org/" title="Home">Home</a> <div class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="Guidelines" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Journals</a> <div class="dropdown-menu" aria-labelledby="Journals"> <a class="dropdown-item" href="https://www.longdom.org/journals-by-title.html" title="A-Z Journals">A-Z Journals</a> <a class="dropdown-item" href="https://www.longdom.org/open-access-journals-list.html" title="Browse By Subject">Browse By Subject</a> </div> </div> <div class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="Guidelines" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Guidelines & Policies </a> <div class="dropdown-menu" aria-labelledby="Guidelines"> <a class="dropdown-item" href="https://www.longdom.org/editorial-policies.html" title="Editorial Policies">Editorial Policies</a> <a class="dropdown-item" href="https://www.longdom.org/submit-manuscript.html" title="Online Submission">Online Submission</a> <a class="dropdown-item" href="https://www.longdom.org/instructions-to-authors.html" title="Instructions to Authors">Instructions to Authors</a> <a class="dropdown-item" href="https://www.longdom.org/policies.html" title="Policies">Policies</a> <a class="dropdown-item" href="https://www.longdom.org/publication-ethics.html" title="Publication ethics & malpractice statement">Publication ethics & malpractice statement</a> <a class="dropdown-item" href="https://www.longdom.org/reviewers.html" title="Reviewers">Reviewers</a> <a class="dropdown-item" href="https://www.longdom.org/terms-conditions.html" title="Terms and Conditions">Terms and Conditions</a> </div> </div> <a class="nav-item nav-link" href="https://www.longdom.org/advertising.html" title="Advertising">Advertising</a> <a class="nav-item nav-link" href="https://www.longdom.org/conferences.html" title="Conferences">Conferences</a> <a class="nav-item nav-link" href="https://www.longdom.org/contact-us.html" title="Contact us">Contact us</a>  <div class="nav-item dropdown multi_lang j_multi_lang"> <a class="nav-link dropdown-toggle" href="#" id="multi_lang" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Language</a> <div class="dropdown-menu" aria-labelledby=""> <a class="dropdown-item" href="https://spanish.longdom.org/developing-drugs/editorial-board.html" title="Spanish"> <img src="/admin/flags/spain.png">Spanish </a> <a class="dropdown-item" href="https://chinese.longdom.org/developing-drugs/editorial-board.html" title="Chinese"> <img src="/admin/flags/china.png">Chinese </a> <a class="dropdown-item" href="https://russian.longdom.org/developing-drugs/editorial-board.html" title="Russian"> <img src="/admin/flags/russia.png">Russian </a> <a class="dropdown-item" href="https://german.longdom.org/developing-drugs/editorial-board.html" title="German"> <img src="/admin/flags/germany.png">German </a> <a class="dropdown-item" href="https://french.longdom.org/developing-drugs/editorial-board.html" title="French"> <img src="/admin/flags/france.png">French </a> <a class="dropdown-item" href="https://japanese.longdom.org/developing-drugs/editorial-board.html" title="Japanese"> <img src="/admin/flags/japan.png">Japanese </a> <a class="dropdown-item" href="https://portuguese.longdom.org/developing-drugs/editorial-board.html" title="Portuguese"> <img src="/admin/flags/portugal.png">Portuguese </a> <a class="dropdown-item" href="https://hindi.longdom.org/developing-drugs/editorial-board.html" title="Hindi"> <img src="/admin/flags/india.png">Hindi </a> <a class="dropdown-item" href="https://telugu.longdom.org/developing-drugs/editorial-board.html" title="Telugu"> <img src="/admin/flags/india.png">Telugu </a> <a class="dropdown-item" href="https://tamil.longdom.org/developing-drugs/editorial-board.html" title="Tamil"> <img src="/admin/flags/india.png">Tamil </a> </div> </div>  </div>  </div> </div> </nav> </header>  <section class="bg-info py-1"> <div class="container"> <div class="row align-items-center justify-content-between">  <div class="col-12 col-sm-auto"> <img src="https://www.longdom.org/admin/headers/journal-of-developing-drugs-logo.svg" alt="Journal of Developing Drugs" width="105" height="105" class="img-fluid mx-auto"> </div> <div class="col-12 col-sm-8"> <h1 class="text-left text-white border-light-blue-200-before font-size-7">Journal of Developing Drugs<br><small class="float-right font-size-5">Open Access</small></h1> </div>  <div class="col-12 col-sm-2 d-none d-sm-block"> <p class="lead">ISSN: 2329-6631</p>  <div id="feedback" class="card card-body p-1 font-size-2 shadow-sm z-index-1"> <div class="reach-us-animated"></div> <p class="card-text"><img src="/assets/img/whatsapp.svg" alt="" width="20" class="ml-2"> +44 1478 350008</p> </div> </div> </div> </div> </section>  <nav id="sticky-navbar" class="navbar navbar-expand-lg navbar-dark bg-primary py-0"> <div class="container"> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#jrnlNavbar" aria-controls="jrnlNavbar" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="collapse navbar-collapse justify-content-center" id="jrnlNavbar"> <div class="navbar-nav"> <a class="nav-item nav-link " href="https://www.longdom.org/developing-drugs.html" title="Journal Home">Journal Home</a> <div class="nav-item dropdown"> <a class="nav-link dropdown-toggle active" href="#" id="EditorialPanel" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Editorial Panel <i class="fas fa-caret-down"></i></a> <div class="dropdown-menu" aria-labelledby="EditorialPanel"> <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/editor-in-chief.html" title="Editor-in-Chief">Editor-in-Chief</a> <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/editorial-board.html" title="Editorial Board">Editorial Board</a> </div> </div> <div class="nav-item dropdown"> <a class="nav-link dropdown-toggle " title="Instructions for Authors" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" href="#">Instructions for Authors <i class="fas fa-caret-down"></i></a> <div class="dropdown-menu" aria-labelledby="EditorialPanel"> <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/instructionsforauthors.html" title="Instructions for Authors">Instructions for Authors</a>  <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/ethical-malpractices.html" title="Publication ethics & malpractice statement">Publication ethics & malpractice statement</a> </div> </div> <a class="nav-link " href="https://www.longdom.org/developing-drugs/submit-manuscript.html" title="Submit Manuscript">Submit Manuscript</a> <a class="nav-link " href="https://www.longdom.org/developing-drugs/aim-and-scope.html" title="Aims and Scope">Aims and Scope</a> <a class="nav-link " href="https://www.longdom.org/developing-drugs/inpress.html" title="Articles in process">Articles in process</a>  <a class="nav-link " href="https://www.longdom.org/developing-drugs/archive.html" title="Archive">Archive</a> <div class="nav-item dropdown"> <a class="nav-link dropdown-toggle " href="#" id="SpecialIssues" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">Special Issues <i class="fas fa-caret-down"></i></a> <div class="dropdown-menu" aria-labelledby="SpecialIssues"> <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/guidelines.html" title="Guidelines">Guidelines</a> <a class="dropdown-item" href="https://www.longdom.org/developing-drugs/upcoming-special-issues.html" title="Upcoming Special Issues">Upcoming Special Issues</a> </div> </div> <a class="nav-item nav-link " href="https://www.longdom.org/developing-drugs/contact.html" title="Contact">Contact</a> </div> </div> </div> </nav> <script type="text/javascript"> function googleTranslateElementInit() { new google.translate.TranslateElement({pageLanguage: 'en'}, 'google_translate_element'); } </script> <script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script> <section class="py-4 content"> <div class="container"> <div class="row"> <aside class="col-12 col-sm-3 order-last order-sm-first"> <a href="https://www.longdom.org/developing-drugs/awards-nomination.html" class="btn btn-info btn-block mb-3 border-0 border-left-4 border-info font-size-4"><i class="fa-light fa-award-simple"></i> Awards Nomination </a> <a href="https://www.longdom.org/developing-drugs-online-visitors-readers-240.html" class="btn btn-warning btn-block mb-3 border-0 border-left-4 border-info font-size-4"><i class="fas fa-book-reader"></i> 25+ Million Readerbase</a>      <h6><a target="_blank" href="https://scholar.google.com/citations?user=z12-SUwAAAAJ&hl=en" title="Click here">Google Scholar citation report</a></h6> <h6 style="font-weight:bold;">Citations : 1586</h6> <p><a target="_blank" href="https://scholar.google.com/citations?user=z12-SUwAAAAJ&hl=en" title="Click here">Journal of Developing Drugs received 1586 citations as per Google Scholar report</a></p> <div class="card shadow-sm sidebar mb-3"> <a href="https://www.longdom.org/developing-drugs/citations.html" title="Click here"><img src="https://www.longdom.org/admin/citation-images/journal-of-developing-drugs-citation.PNG" alt="Citation" class="img-fluid p_rel" /></a> </div> <h6><a href="https://publons.com/journal/31030/journal-of-developing-drugs/" target="_blank" title="Click here">Journal of Developing Drugs peer review process verified at publons</a></h6> <div class="card shadow-sm sidebar mb-3"> <a href="https://publons.com/journal/31030/journal-of-developing-drugs/" target="_blank" title="Click here"><img src="https://www.longdom.org/admin/publon-images/journal-of-developing-drugs-publon.png" alt="Flyer image" class="p_rel w-100" height="250px"/></a> </div>   <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header pr-0">Indexed In</h6> <div class="list-group list-group-flush overflow-view"> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Open J Gate </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> SafetyLit </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> RefSeek </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Hamdard University </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> EBSCO A-Z </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> OCLC- WorldCat </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Publons </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Euro Pub </div> <div class="list-group-item p-0 pt-2 pl-2"> <i class="fa fa-chevron-right" style="font-size: 11px;color: #0056b3;"></i> Google Scholar </div> </div> <p class="m-0 clearfix"><a href="https://www.longdom.org/developing-drugs/indexing.html" title="Click here"><span class="btn btn-warning btn-xs float-right">View More »</span></a></p> </div>   <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header">Useful Links</h6> <div class="card-body p-0"> <nav class="nav flex-column font-size-3 icon-list icon-list-angle-right a-py-1"> <a class="nav-item nav-link" href="https://www.longdom.org/covid-19-peer-reviewed-journals-articles-special-issues.html" title="Click Here">Covid-19 Journal Articles Issues</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/aim-and-scope.html" title="Click Here">Aim and Scope</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/peer-review-process.html" title="Click Here">Peer Review Process</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/other-comments.html" title="Click Here">Other Comments</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/advertising.html" title="Click Here">Advertising</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/citations.html" title="Click Here">Citations Report</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/indexing.html" title="Click Here">Indexing and Archiving</a> <a class="nav-item nav-link" href="https://www.longdom.org/developing-drugs/archive.html" title="Click Here">Table of Contents</a> <a class="nav-item nav-link" href="https://www.longdom.org/submissions/developing-drugs.html" title="Click Here">Submit Paper</a> <a class="nav-item nav-link" href="https://www.longdom.org/editorial-tracking/" title="Click Here">Track Your Paper</a> <a class="nav-item nav-link" href="https://www.longdom.org/funded-articles.html" title="Click Here">Funded Work</a> </nav> </div> </div>  <div class="card shadow-sm sidebar mb-3" style="margin-top:10px"> <h6 class="card-header">Share This Page</h6> <div class="card-body"> <nav class="nav social-icons social-icons-sm"> <a class="nav-link bg-facebook white" href="https://www.facebook.com/sharer.php?u=https://www.longdom.org/developing-drugs/editorial-board.html" target="_blank" title="Share with Facebook" rel="noopener"><i class="fab fa-facebook-f"></i></a> <a class="nav-link bg-twitter white" href="https://twitter.com/share?url=https://www.longdom.org/developing-drugs/editorial-board.html" rel="noopener" target="_blank" title="Share with Twitter"><i class="fab fa-twitter"></i></a> <a class="nav-link bg-linkedin white" href="https://www.linkedin.com/shareArticle?mini=true&url=https://www.longdom.org/developing-drugs/editorial-board.html" rel="noopener" target="_blank" title="Share with Linkdin"><i class="fab fa-linkedin-in"></i></a> <a class="nav-link bg-googleplus white" href="https://plus.google.com/share?url=https://www.longdom.org/developing-drugs/editorial-board.html" target="_blank" rel="noopener" title="Share with Google+"><i class="fab fa-google-plus-g"></i></a> <a class="nav-link bg-pinterest white" href="https://pinterest.com/pin/create/button/?url=https://www.longdom.org/developing-drugs/editorial-board.html" rel="noopener" target="_blank" title="Share with Pintrest"><i class="fab fa-pinterest-p"></i></a> <a class="nav-link bg-blogger white" href="https://www.blogger.com/blog-this.g?u=https://www.longdom.org/developing-drugs/editorial-board.html" rel="noopener" target="_blank" title="Share with Blogger"><i class="fab fa-blogger-b"></i></a> </nav> </div> </div>  <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header">Recommended Journals</h6> <div class="card-body p-0"> <nav class="nav flex-column font-size-3 icon-list icon-list-angle-right a-py-1"> <a class="nav-item nav-link" href="https://www.longdom.org/alcoholism-and-drug-dependence.html" title="Click Here">Drug Dependences</a> <a class="nav-item nav-link" href="https://www.longdom.org/drug-metabolism-toxicology.html" title="Click Here">Toxicology</a> <a class="nav-item nav-link" href="https://www.longdom.org/biomedical-engineering-medical-devices.html" title="Click Here">Biomedical Drugs</a> </nav> </div> </div>  <div class="card shadow-sm sidebar mb-3"> <a href="https://www.longdom.org/developing-drugs/advertising.html" title="Click here"><img src="https://www.longdom.org/assets/img/tower-banner.jpg" alt="Flyer image" class="img-fluid p_rel" /> <span class="p_abo cu_roundchip"> <span> <h5><span>25+</span> Million Website Visitors</h5> <h5><span>1450+</span> Journal Visitors</h5> </span> </span> </a> </div>    <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header">Journal Flyer</h6> <img src="https://www.longdom.org/admin/flyers/journal-of-developing-drugs-flyer.jpg" alt="Journal of Developing Drugs" class="img-fluid"/> </div>   <div class="sidebar pt-20 pl-10 mt-xs-0" align="center"> <a class="twitter-timeline" href="https://twitter.com/Developing_drug" data-width="450" data-height="300">Tweets by Developing_drug</a> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> </div> <div class="clear"> </div>   <div class="card shadow-sm sidebar mb-3"> <h6 class="card-header">Open Access Journals</h6> <div class="card-body p-0 scroll_mang"> <nav class="nav flex-column font-size-3 icon-list icon-list-angle-right a-py-1"> <a class="nav-item nav-link" href="https://www.longdom.org/agri-and-aquaculture-journals.html" title="Click Here">Agri and Aquaculture</a> <a class="nav-item nav-link" href="https://www.longdom.org/biochemistry-journals.html" title="Click Here">Biochemistry</a> <a class="nav-item nav-link" href="https://www.longdom.org/bioinformatics-and-systems-biology-journals.html" title="Click Here">Bioinformatics & Systems Biology</a> <a class="nav-item nav-link" href="https://www.longdom.org/business-and-management-journals.html" title="Click Here">Business & Management</a> <a class="nav-item nav-link" href="https://www.longdom.org/chemistry-journals.html" title="Click Here">Chemistry</a> <a class="nav-item nav-link" href="https://www.longdom.org/clinical-sciences-journals.html" title="Click Here">Clinical Sciences</a> <a class="nav-item nav-link" href="https://www.longdom.org/engineering-journals.html" title="Click Here">Engineering</a> <a class="nav-item nav-link" href="https://www.longdom.org/food-and-nutrition-journals.html" title="Click Here">Food & Nutrition</a> <a class="nav-item nav-link" href="https://www.longdom.org/general-science-journals.html" title="Click Here">General Science</a> <a class="nav-item nav-link" href="https://www.longdom.org/genetics-and-molecular-biology-journals.html" title="Click Here">Genetics & Molecular Biology</a> <a class="nav-item nav-link" href="https://www.longdom.org/immunology-and-microbiology-journals.html" title="Click Here">Immunology & Microbiology</a> <a class="nav-item nav-link" href="https://www.longdom.org/medical-sciences-journals.html" title="Click Here">Medical Sciences</a> <a class="nav-item nav-link" href="https://www.longdom.org/neuroscience-and-psychology-journals.html" title="Click Here">Neuroscience & Psychology</a> <a class="nav-item nav-link" href="https://www.longdom.org/nursing-and-health-care-journals.html" title="Click Here">Nursing & Health Care</a> <a class="nav-item nav-link" href="https://www.longdom.org/pharmaceutical-sciences-journals.html" title="Click Here">Pharmaceutical Sciences</a> </nav> </div> </div>  </aside> <main class="col-12 col-sm-9 main"> <h2 class="heading-1">Editorial Board</h2> </h3> <ul class="list-group list-group-flush"> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--yavuz-s-silay-8795.jpg" alt="Yavuz S Silay" title="Yavuz S Silay" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/yavuz-s-silay-4577" title="Click here"><strong>Yavuz S Silay</strong></a>, Ms, Phd <br>Editor-in-Chief <br>Director, Therapeutic Medical Head, Teva Neurosciences Commercial Organization <br>Hampton University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Silay is an Executive Physician Scientist, certified Clinical Research Professional in the Pharmaceutical industry with an Executive MBA degree from the Oline Business School at Washington University in St. Louis which is ranked #2 by Wall Street Journal. Dr. Silay is a member of American Academy of Neurology, DIA (Drug Information Association) SIAC’s for Good Clinical Practice/Quality Assurance Special Interest Activity Community (GCP/QA SIAC), Clinical Trial Registry/Results Disclosure Working Group (CTR/RD Working Group), Natural Health Products, MDS (Movement Disorder Society) current chair of TABID (Turkish American Business Improvement Council) for Healthcare and Pharmaceutical Industry, Charter and previous president of AMSA (American Medical Student Association) Turkey and previous president of SOCRA (Society of Clinical Research Associates) in New Jersey. Dr. Silay, a permanent resident of U.S.A. was born in Turkey and educated in Turkey, Germany and U.S.A. He completed his medical school from The University of Ankara in Turkey and his internship at Baylor College of Medicine and University of Texas in Houston, Texas. He was trained in a Physician Scientist Training Program at The MD Anderson Cancer Center of University of Texas. As a prolific scientific writer he published extensively with more than 15 peer reviewed article and more than 50 platform and abstract presentation at the academic and industry level in national and international meetings. Dr. Silay joined Teva Neuroscience on May 2009 and is currently the Head of Clinical and Medical Parkinson’s franchise as the Director of Scientific Affairs and Medical Research in U.S Headquarter in Kansas City reporting to Chief Medical Officer and VP of Medical Affairs. He is also responsible for the Parkinson’s disease Investigator Initiated Trials, Phase IIIB, Phase IV trials and for developing relationships with Key Opinion Leaders in the field of Neurology. He gained experience in therapeutic areas within pulmonary critical care, transplant, CNS and rheumatologic conditions such as, Fibromyalgia, Alzheimer, MS, Epilepsy, Autism and Parkinson’s disease." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Clinical development and medical affairs experience and interest in Internal Medicine (Pulmonary & Critical care, Asthma, CF, Sarcoidosis, Lung transplant Diabetic Neuropathy), Neurology (Movement disorders, Parkinson′s Huntington′s, Tourette, Alzheimer, DBS, Botox, Autism, Epilepsy, Head trauma), Psychiatry (Schizophrenia, Bipolar), Rheumatology, Pain (Fibromyalgia, Osteoarthritis), CFS, GI (anti emetics), Growth Hormone, Hematology, Oncology, Women′s health." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--walter-j-lukiw-8821.jpg" alt="Walter J Lukiw" title="Walter J Lukiw" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/walter-j-lukiw-4589" title="Click here"><strong>Walter J Lukiw</strong></a> <br>Executive Editor <br>Associate Professor, Department of Ophthalmology <br>Louisiana State University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Walter J. Lukiw, Associate Professor, Neuroscience and Ophthalmology, LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Health Sciences Center, School of Medicine, US." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Alzheimer’s disease, Bioinformatics, Brain gene transcription, Chromatin structure, Complexity, DNA polymorphisms, Environmental health, Genetic evolution, Genotoxicity, Inflammation, Memory, Neurodegeneration, Neurological disorders, Neurotoxicity, Messenger RNA, Micro RNA (miRNA), Oxidative stress, Prion diseases, Sleep cycles, Small RNA, Trace metals." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--ritu-aneja-8822.jpg" alt="Ritu Aneja" title="Ritu Aneja" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/ritu-aneja-4590" title="Click here"><strong>Ritu Aneja</strong></a> <br>Executive Editor <br>Associate Professor, Department of Biology <br>Georgia State University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Ritu Aneja, Associate Professor in the Department of Biology from Georgia State University. She has done her PhD from University of Delhi in 1997. She completed her MS(Gold medalist) in chemistry from University of Delhi. She is Adjunct Associate Professor, Tuskegee University, AL and Adjunct Associate Professor, Center for Cancer Research and Therapeutic Development (CCRTD), Clark Atlanta University. She got Post-Doctoral Fellow trainings from Department of Cell Biology, Emory University and Department of Internal Medicine, Yale University." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Cytoskeletal Microtubules, Cell Cycle and Cancer." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--syed-aa-rizvi-11276.jpg" alt="Syed AA Rizvi" title="Syed AA Rizvi" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/syed-aa-rizvi-4619" title="Click here"><strong>Syed AA Rizvi</strong></a>, Ms, Phd <br>Executive Editor <br>Assistant Professor, Department of Pharmaceutical Sciences <br>Hampton University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D’Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization. Moreover, Dr. Rizvi pursued part time postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. Dr. Rizvi has published many peer-reviewed articles (cited over 600 times) in top ranking journals and two book chapters. Dr. Rizvi publications include one of the most highly rated article, two cover articles and one figure from Dr. Rizvi’s paper was included in the text book “Quantitative Chemical Analysis” by Daniel C. Harris (7th Edition, p 616, W. H. Freeman, 2006, ISBN-10: 0716770415). Dr. Rizvi also presented his work through posters and oral presentations in national and international conferences. Dr. Rizvi also serves as editor-in-chief, the editorial board member of several scientific journals and review papers for more than 20 different journals. Dr. Rizvi enjoys teaching and engaging students in thought process, beside creative cooking at home and practicing martial arts." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Micro and Nano-Technology for Drug Delivery, Controlled Release Formulations, Solid State Chemistry of the Drugs, Surface Chemistry, Analytical Chemistry, Soft Material Chemistry, Forensic Chemistry, Organic Chemistry, Natural Product Chemistry, Vaccinology and Immunology." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--jair-c-soares-8800.jpg" alt="Jair C Soares" title="Jair C Soares" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/jair-c-soares-4580" title="Click here"><strong>Jair C Soares</strong></a> <br>Professor, Department of Psychiatry and Behavioral Sciences <br>University of Texas Medical School, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Jair C. Soares, Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston and Executive Director, Harris County Psychiatric Center. He has edited or co-edited three textbooks, has published over 120 peer-reviewed articles and book chapters in psychiatric literature, and he co-edited the peer-review journal “Bipolar Disorders-An International Journal of Psychiatry and Neurosciences”." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Soares has extensive clinical research experience in the field of mood disorders, as well as brain imaging modalities and neurocognitive methods to investigate the pathophysiology of bipolar disorder and the mechanisms of action of pharmacological treatments." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--hector-o-ventura-8801.jpg" alt="Hector O Ventura" title="Hector O Ventura" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/hector-o-ventura-4581" title="Click here"><strong>Hector O Ventura</strong></a> <br>Professor, Department of Medicine <br>Tulane University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Hector O. Ventura, MD, is the Assistant DIO, Graduate Medical Education Committee and the Section Head, Cardiomyopathy and Heart Transplant Center at the Ochsner Clinic Foundation, New Orleans, Louisiana. He is also a Professor, Cardiology, University of Queensland School of Medicine, Ochsner Clinical School, Brisbane, Australia as well as a Professor of Medicine at the Tulane University School of Medicine in New Orleans. He completed an internship and residency at the Central Military Hospital in Buenos Aires, followed by research fellowships in arterial hypertension and cardiovascular diseases, an internship, and an internal medicine residency at the Ochsner Medical Institutions in New Orleans." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Arterial hypertension following cardiac transplantation, the effect of digitalis on mortality in heart failure, Lipid profiles after cardiac transplantation." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--kenneth-maiese-10272.jpg" alt="Kenneth Maiese" title="Kenneth Maiese" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/kenneth-maiese-4601" title="Click here"><strong>Kenneth Maiese</strong></a> <br>Professor, Department of Neurology and Neurosciences <br>New Jersey Health Sciences University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Kenneth Maiese is Professor and Head of Cellular and Molecular Signaling at New Jersey Health Sciences University. Dr. Maiese has been fortunate to receive recognition with outstanding teaching awards and election to America′s Top Physicians, the Best of U.S. Physicians, and Top Doctors. His investigations are designed to translate basic science into successful therapeutic treatments for conditions such as cancer, metabolic disorders, cardiovascular disease, diabetes, stroke, and Alzheimer′s disease. He is a top cited author with continuous funding from the American Diabetes Association, the American Heart Association, the Bugher Foundation, a Johnson and Johnson Focused Giving Award, and the NIH. Dr. Maiese holds several patents, has over 300 publications and has authored 5 books. Dr. Maiese also serves as the Editor-in-Chief, Associate Editor, or editorial board member for more than 60 journals as well as on multiple executive committees, technology panels, and scientific advisory councils." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Translational drug development, Oxidative stress, Cell signaling, Transcription factors, Apoptosis, Autophagy" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--patricia-l-darbishire-10534.jpg" alt="Patricia L Darbishire" title="Patricia L Darbishire" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/patricia-l-darbishire-4607" title="Click here"><strong>Patricia L Darbishire</strong></a> <br>Associate Professor, College of Pharmacy <br>Purdue University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Patti Darbishire is a Clinical Associate Professor of Pharmacy Practice and Director for the Introductory Pharmacy Practice Experience Program at Purdue University. She teaches pharmacy practice, research-based independent study and experiential courses in the professional pharmacy program. She is a Service-Learning faculty fellow, faculty fellow with the Purdue Center for Instructional Excellence, and an active member of the American Association of Colleges of Pharmacy. She is an editorial board member for two peer-review journals, has published 18 peer reviewed articles on medications, disease states and experiential program development. She regularly gives national, state, and local presentations to pharmacists, healthcare providers and community organizations. Dr. Darbishire has received numerous awards and grants including Purdue Preceptor of the Year, assessment and engagement grants, as well as a HRSA grant to develop a comprehensive geriatric education program" data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Darbishire has developed clinical programs in community practice, ambulatory care, hospice care, and with underserved populations. Her research interests include medication management, community pharmacy operations, patient education and counseling, medication error prevention, medication adherence, as well as assessment methods and learning outcomes. She holds state and national certifications in several practice areas, including pharmaceutical care, diabetes management, and Medicare." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--michael-f-wempe-10503.jpg" alt="Michael F Wempe" title="Michael F Wempe" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/michael-f-wempe-4605" title="Click here"><strong>Michael F Wempe</strong></a> <br>Associate Research Professor and Director, Department of Pharmaceutical Sciences, School of Pharmacy <br>University of Colorado, Denver, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Wempe is a Physical/Synthetic Organic Chemist (PhD) with Chemical and Pharmaceutical work experience.His laboratory uses chemical synthesis (organic and bio-organic) to produce known and novel compounds which are subsequently screened (in vitro and in vivo) for biological activity; his laboratory conducts fundamental research in drug development (metabolism, pharmacokinetics, and toxicity). Research activities include: i) Medicinal Chemistry - rational drug design and Structure-Activity Relationship (SAR) elucidation; ii) computational chemistry; iii) developing novel technology to improve oral bioavailability of small molecules; and iv) bio-analytical methodology development.There are a variety of research activities occurring within his laboratory;two major efforts include the development of LAT1 selective inhibitors for use in cancer research and therapy, and another involves the development of URAT transporter inhibitors in the development of novel cardiovascular agents. Dr. Wempe is the Director of the Medicinal Chemistry Core facility at the University of Colorado, Anschutz medical campus." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Research activities include: i) Medicinal Chemistry - rational drug design and Structure-Activity Relationship (SAR) elucidation; ii) computational chemistry; iii) developing novel technology to improve oral bioavailability of small molecules; and iv) bio-analytical methodology development" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--igor-astsaturov-8831.jpg" alt="Igor Astsaturov" title="Igor Astsaturov" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/igor-astsaturov-4597" title="Click here"><strong>Igor Astsaturov</strong></a> <br>Department of Medical Oncology, Fox Chase Cancer Center <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Igor Astsaturov, Assistant member from Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia. He has done Internship and Residency in Internal Medicine, Good Samaritan Hospital, Baltimore, MD and PhD in Hematology/Oncology, Russian Hematological Research Center, Moscow." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Intrinsic and acquired cellular resistance limits the efficacy of EGFR targeted cancer therapeutics. Rational and more efficacious combinations of targeted therapeutics, siRNA screening to comparatively probe the signaling network for proteins that regulate the effectiveness of both targeted (EGFR being the prime target) and chemotherapeutic agents, New synergistic targets with EGFR antagonists as a direct path to clinical exploitation of study results including distal sterol biosynthesis pathway metabolic enzymes such as SC4MOL and NSDHL using cellular systems and an animal model of conditional NSDHL deficiency. Explorations of new metabolic targets for cancer therapy involving these previously unexplored sterol pathway genes." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--emmanuel-andres-10542.JPG" alt="Emmanuel Andres" title="Emmanuel Andres" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/emmanuel-andres-4609" title="Click here"><strong>Emmanuel Andres</strong></a> <br>Professor, Department of Internal Medicine <br>University of Strasbourg, France </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="In 1996, Dr Andrès received his MD degree in Internal Medicine, at the University Of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of >60 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical companies or start-up. In 2007, He was nominated in the French National Commission of Pharmacovigilance." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Development of an electronic stethoscope "intelligent" and basic research and clinical auscultation human. Development work and research projects in the field of telemedicine and the contribution of new technologies to support chronic disease and old age (COPD, diabetes, Alzheimer′s...). Clinical research activity in Internal Medicine and Hematology with the following themes: anemia, neutropenia and agranulocytosis drug, idiopathic thrombocytopenic purpura, research activity in the field of Metabolism including deficiencies in vitamin B12. Clinical research activity on Orphan Diseases Developing a biobank of samples from the body of people with common pathologies complex (BIOMAX)." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--niraldo-paulino-10366.JPG" alt="Niraldo Paulino" title="Niraldo Paulino" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/niraldo-paulino-4603" title="Click here"><strong>Niraldo Paulino</strong></a> <br>Professor, Department of Pharmacology <br>Universidade Bandeirante de São Paulo, Brazil </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Niraldo Paulino is Professor at Universidade Bandeirante de São Paulo and Chief Research and Development of BIOMED Group in the Pharmacy Program. He received his pharmaceutical degree from the Universidade Federal de Santa Catarina, Florianópolis, SC Brazil and completed his doctor degree at the same university in collaboration with Ludwig Maximilian University in Germany. He has experience in Pharmacology, focusing on medicinal plants pharmacology, molecular pharmacology and cellular signaling. The special area of interest is: medicinal plants (Brazilian species). propolis, inflammation, and molecular mechanisms of action of natural products and bioactive synthetics. He has several publications and patent and is one of the leading research experts in the Brazilian propolis and its actions and applications. He serves on various review committees including Chef-Editor in Revista de Pesquisa e Inovação Farmacêutica in Brazil." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="The special area of interest is: medicinal plants (Brazilian species). propolis, inflammation, and molecular mechanisms of action of natural products and bioactive synthetics." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/8799-Editor-Photo.jpg" alt="Antonio Russo" title="Antonio Russo" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/antonio-russo-4579" title="Click here"><strong>Antonio Russo</strong></a> <br>Professor, Department of Surgical and Oncological Sciences <br>University of Palermo, Italy </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Antonio Russo received his MD from University Medical School of Palermo, Italy in 1982. His post-graduate speciality were Medical Genetic and Medical Oncology. Since 2008, he is Associate Professor of Medical Oncology and Chief of Genetic and Molecular Oncology Unit at University Medical School of Palermo. Since 2004, he is an Adjunct Associate Professor Temple University’s, Philadelphia USA and since 2011, he is an Adjunct Full Professor Temple University, Philadelphia, USA. He is Expert member of INSERM, INCA, NWCRF. The central theme of his studies is translational and clinical research, meaning the application of molecular genetics in routine malignant tumors. He is author for more than 200 publications in top-rated cancer journal." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy and targeted therapies of solid tumors, Prognostic and predictive biomolecular indicators of therapeutic response to monoclonal antibodies and to tyrosine kinase inhibitors in solid tumours, Molecular genetics, prevention and therapies of hereditary and familial tumors especially those of the breast/ovary and of the gastrointestinal tract." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--carlo-enrico-traverso-8820.jpg" alt="Carlo Enrico Traverso" title="Carlo Enrico Traverso" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/carlo-enrico-traverso-4588" title="Click here"><strong>Carlo Enrico Traverso</strong></a> <br>Professor, Department of Neuroscience <br>University of Genova, Italy </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Carlo E. Traverso received his MD degree from the University of Genova Medical School, where he also attended the Residency program under Professor Mario Zingirian. He attended the Wills Eye Hospital in Philadelphia, for subspecialty training in Glaucoma with George L. Spaeth, MD and in Cornea with Peter Laibson, MD (1981-1983), and King Khaled Eye Specialist Hospital in Riyadh where he worked for 3.5 years (1985-1988). He has been since at the University Eye Clinic in Genova, Present position: Director of Residency Program in Ophthalmology. Chairman of Clinica Oculistica, Department of Neurosciences, Ophthalmology and Genetics, University of Genova-Azienda Ospedaliera Universitaria “San Martino”. Medical Director of Melvin Jones Eye Bank of Genova. Member of the Executive Committee of the European Glaucoma Society (EGS) as President." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Glaucoma, Cornea, Cataract, Health Ecomomics." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--daniele-santini-8826.jpg" alt="Daniele Santini" title="Daniele Santini" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/daniele-santini-4593" title="Click here"><strong>Daniele Santini</strong></a> <br>Associate Professor, Department of Medical Oncology <br>Policlinico Universitario, Italy </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Daniele Santini, Associate Professor, Department of Medical Oncology, Policlinico Universitario, ItalyUniversity “La Sapienza”, Rome, Italy. He graduated cum laude Medicine and Surgery degree from University La Sapienza, Rome, Italy, Graduated cum laude Resident-Specialty in Medical Oncology, PhD in Immunopharmacology." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy in gastrointestinal tumors, Molecular mechanisms on tumor progression, Molecular prognostic and predictive factors in gastrointestinal tumors, Role of bisphosphonates and emerging target therapies in Osteoncology (denosumab, Src inhibitors, Catepsine K inhibitors, Endothelin A inhibitors, Wnt/dkk agonist/antagonists, TGF beta inhibitors, etc.) Molecular Factors predictive of response to monoclonal antibodies and to tyrosine kinase inhibitors in solid tumors (EGFR inhibitors, Multitarget TKis, Antiangiogenic drugs, mTOR inhibitors, etc)." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--massimo-serra-8830.jpg" alt="Massimo Serra" title="Massimo Serra" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/massimo-serra-4596" title="Click here"><strong>Massimo Serra</strong></a> <br>Chief of Pharmacogenomics and Pharmacogenetics, Laboratory of Experimental Oncology, Orthopaedic Rizzoli Institute <br>Italy </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Massimo Serra got the Degree in Biological Sciences (score of 110 out of 110, with high honours). Since 1989, he is employed as Staff Researcher (Biologo Dirigente I Livello) at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute, I.R.C.C.S.(Bologna, Italy). He also worked abroad as Research Fellow at the "Molecular Genetics Laboratory" (Salk Institute, San Diego, CA) in 1993 and as Research Fellow at the "Cytogenetics and Molecular Genetics Laboratory" of the University of Helsinki (Finland) in 1997. From 1999 to 2008, he has been the Chief of the "Drug Resistance" Research Unit (Modulo Organizzativo), which was upgraded to the "Pharmacogenomics and Pharmacogenetics" Research Unit (Struttura Semplice) on 2009, at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute. From 1998 to 2008, he has been member of the Scientific Committee of the Orthopaedic Rizzoli Institute and of the Directive Committee of the Musculo-Skeletal Oncology, department of the Orthopaedic Rizzoli Institute. Since 2009, he is member of the Direction Committee of the Orthopaedic Rizzoli Institute." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="•Analysis of the genetic and molecular mechanisms responsible for drug resistance in the most common bone and soft-tissue sarcomas, as well as on the genetic background associated with a differential drug sensitivity in osteosarcoma. •Pharmacogenomic and pharmacogenetic characterisation of the most common musculoskeletal tumours, with particular regard to osteosarcoma. •Analysis of genetic and molecular mechanisms responsible for resistance to doxorubicin, methotrexate and cisplatin in human osteosarcoma cells. •Preclinical validation of candidate prognostic and therapeutic markers in osteosarcoma and other bone tumor patients. •Preclinical evaluation of the efficacy of new target-specific drugs and innovative therapeutic approaches for osteosarcoma and analysis of their interactions with conventional chemotherapeutic drugs and regimens." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--warren-p-mason-8823.jpg" alt="Warren P Mason" title="Warren P Mason" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/warren-p-mason-4591" title="Click here"><strong>Warren P Mason</strong></a> <br>Associate Professor, Department of Medicine <br>University of Toronto, Canada </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Mason is the medical director of the largest multidisciplinary treatment centre for brain tumors in Canada. In addition to his clinical and research activities at the Princess Margaret Hospital, He is also the chair of the brain disease site group of the NCIC Clinical Trials Group. Dr. Mason graduated in medicine from the University of Toronto, and completed residences in Internal Medicine and Neurology at the University of Toronto and McGill University, Montreal. He received fellowship training in neurooncology at Memorial Sloan-Kettering Cancer Center in New York." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Development of medical therapies for primary brain tumors." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--ofer-agid-8827.jpg" alt="Ofer Agid" title="Ofer Agid" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/ofer-agid-4594" title="Click here"><strong>Ofer Agid</strong></a> <br>Department of Psychiatry <br>University of Toronto, Canada </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Ofer Agid, Assistant Professor of Psychiatry-Department of Psychiatry, University of Toronto. He has completed B. Med Sc. from Hebrew University, Jerusalem, Israel. MD from Medical School of Hadassah, Hebrew University, Jerusalem, Israel. He is presently appointed as a Clinical Chief in first episode division, schizophrenia Program, Centre for Addiction and Mental Health. (Since 2010) Medical Leader-Home Intervention for Psychosis team, schizophrenia Program, Centre for Addiction and Mental Health." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Schizophrenia, First episode, Antipsychotics, Trajectory of response." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--donat-koegel-8798.jpg" alt="Donat Koegel" title="Donat Koegel" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/donat-koegel-4578" title="Click here"><strong>Donat Koegel</strong></a> <br>Head of Experimental Neurosurgery, Department of Neurosurgery <br>Frankfurt University, Germany </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Donat Kögel is currently the Head of the Section of Experimental Neurosurgery at the Goethe-University Hospital in Frankfurt. His research focuses on the molecular events leading to gliomagenesis, as well as apoptosis deficiency and therapy resistance of glioblastoma multiforme, the most malignant and deadly human primary brain tumor. Currently, his research focuses on investigating novel genetic insight-based therapeutic strategies for the treatment of gliomas in cell culture models and in transplantable syngeneic animal tumor models. Another major aim in Donat Kögel´s lab is to identify the relevant pathophysiological stress stimuli and apoptotic signalling pathways implicated in apoptotic neuron death in stroke, Alzheimer´s disease and Parkinson´s disease. Here, he has made important contributions to decipher the molecular mechanisms underlying neuronal cell death, the transcriptional responses to pathophysiological stress in neurons, and neuroprotective signalling pathways modulated by lesion-induced cytokines in the brain." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Mechanisms of programmed cell death, Acute and chronic cns damage, Neuronal stress signalling, Physiological and pathophysiological roles of the amyloid precursor protein and its family members, Mitochondrial control of cell death, Target-specific therapies for the treatment of brain tumors, Oncogenic signalling pathways, Autophagy in health and disease, Mechanisms of tumor cell migration and invasion." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--michael-beck-8804.jpg" alt="Michael Beck" title="Michael Beck" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/michael-beck-4583" title="Click here"><strong>Michael Beck</strong></a> <br>Professor, Department for Lysosomal Storage Disorders <br>University of Mainz, Germany </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Michael Beck, Professor of Children Hospital from University of Mainz, Germany Education and Scientific Training, Pediatrics, Genetics, Biochemistry. He is Head of the Department for Lysosomal Storage Disorders at the Children Hospital University of Mainz (Villa Metabolica). He has given presentations at International Meetings. Over 100 presentations were given at various scientific international meetings. He got memberships of Societies, Deutsche Gesellschaft für Kinderheilkunde, Deutsche Gesellschaft für Humangenetik, SSIEM (Society for the Study of Inborn Errors of Metabolism), ESPR (European Society for Paediatric Research), ESGLD (European Study Group on Lysosomal Diseases), ASHG (American Society Human Genetics). He has more than 200 publications, mostly in peer-reviewed international journals Mainz, August 8, 2011." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Pediatrics, Metabolic disorders, Lysosomal storage disorders, Genetics, Orphan disease." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--klaus-podar-8824.JPG" alt="Klaus Podar" title="Klaus Podar" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/klaus-podar-4592" title="Click here"><strong>Klaus Podar</strong></a> <br>Associate Professor <br>University of Heidelberg, Germany </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Klaus Podar, MD degree from the Medical University of Vienna, his MSc. from the University of Vienna/Faculty of Life Sciences, and his PhD from the University of Vienna/Faculty of Life Sciences and Harvard Medical School, where he joined the Faculty in 2004. In 2009 Dr. Podarmoved to the NCT, University of Heidelberg and DKFZ, where he accepted the position of a hematologist/oncologist and research group leader. Dr. Podar has presented numerous lectures at both national and international meetings; has published more than 100 peer-reviewed scientific articles, educational book chapters, and state-of-the-art reviews both in basic as well as clinical research; is the recipient of numerous awards; member of professional societies including ASH, AACR, and EHA; and serves on the editorial board of several scientific journals. His lab investigates signal transduction pathways within the tumor microenvironment (e.g. multiple myeloma), which support tumor cell survival, proliferation, migration and drug resistance." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Signal transduction, Tumor microenvironment, Cell migration, Cell proliferation, Tumor cel survival, Tumor angiogenesis, Novel targeted therapies." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--daniel-alexander-beyer-8805.jpg" alt="Daniel Alexander Beyer" title="Daniel Alexander Beyer" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/daniel-alexander-beyer-4584" title="Click here"><strong>Daniel Alexander Beyer</strong></a> <br>Professor, Department of Obstetrics and Gynaecology <br>Schleswig-Holstein University, Germany </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Daniel Alexander Beyer is a Senior Consultant Physician and Head of department of Gynaecological Colposcopy and Cervical Dysplasia, Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility at Schleswig-Holstein University, Germany. He has done his MD and BS from Saarland University Medical School, Germany." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Cervical colposcopy and dysplasia, Gynaecological laparoscopic surgery, Reproductive medicine and gynaecological endocrinology, Kisspeptine, Vitrifikation of 2PN zygotes, Clinical research concerning: reproductive medicine and follow-up risk pregnancies." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--tadeusz-robak-8803.jpg" alt="Tadeusz Robak" title="Tadeusz Robak" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/tadeusz-robak-4582" title="Click here"><strong>Tadeusz Robak</strong></a> <br>Professor, Department of Hematology <br>Medical University of Lodz, Poland </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Tadeusz Robak is presently working as Professor of Hematology at the Medical University of Lodz and since 1997 he is Head of the Department of Hematology, at the Medical University and Copernicus Memorial Hospital in Lodz, Poland. He studied medicine at Medical University of Lodz and obtained his approval as hematologist in 1985 and clinical pharmacologist in 1987. In addition, he undertook further postgraduate training at Hammersmith Hospital and Royal Postgraduate Medical School in London. In 1996-2002 he was vice-rector and rector of the Medical University of Lodz. Professor Robak is a chairmen of the CLL subgroup of the Polish Adult Leukemia Study Group. He has written more than 500 journal articles 450 abstracts and 18 books or chapters. His special interests are on the application of nucleoside analogs and monoclonal antibodies in the treatment of leukemia and lymphoma. Professor Robak is involved in many translational research projects and was the principal investigator for several clinical trials of new drugs in leukemia, lymphoma and multiple myeloma. Prof. Tadeusz Robak has been selected by the World Scientists Forum for "Eminent Scientist of the year 2010" International Award in the field of Hematology-Oncology based on his research." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Preclinical and clinical studies of nucleoside analogs and monoclonal antibodies in leukemia and lymphoma." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--paraskevi-papaioannidou-10514.jpg" alt="Paraskevi Papaioannidou" title="Paraskevi Papaioannidou" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/paraskevi-papaioannidou-4606" title="Click here"><strong>Paraskevi Papaioannidou</strong></a> <br>Professor, Department of Pharmacology <br>Aristotle University of Thessaloniki, Greece </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Paraskevi Papaioannidou is a professor of Pharmacology in Medical Faculty of the Aristotle University of Thessaloniki, Greece. She graduated in Chemistry and Medicine at the Aristotle University of Thessaloniki, and she has a PhD in Pharmacology. She had a post-graduate education in the University of Alberta, Canada, and a post-doctoral education in Unicam Laboratories, Cambridge, UK. She has a long academic career in the Aristotle University of Thessaloniki, she was the first tutor and organizer of courses in Pharmacology in the newly-established University of Thessaly, Greece, and she was a visiting researcher in the University of Bologna and the University of Novi Sad, Serbia. She has a considerable collaboration in international research projects (including collaboration with ΝΙΗ, Bethesda, USA), she has created two European research networks (Follicle net and AntibioSurv) and she is the organizer and leader of the international research project ASPPOC. She is evaluator of the Greek Ministry of Education on European Research Projects, member of the Committee on European Educational Programs of the Aristotle University of Thessaloniki, reviewer and member of the Editorial Board of peer-review scientific journals, and organizer of International and Greek scientific Congresses. Currently she is a member of the Board of Directors of DOATAP (Hellenic NARIC), a member of the Executive Committee of the Greek Society of Pharmacology, and Vice-President of “Saint-George” (the Association of people from Korissos)." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Antimicrobial Chemotherapy – Reproductive Pharmacology – Gender-related Pharmacology – Environmental Pharmacology – Prostaglandins – Drug Interactions" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--hisham-ibrahim-8810.jpg" alt="Hisham Ibrahim" title="Hisham Ibrahim" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/hisham-ibrahim-4585" title="Click here"><strong>Hisham Ibrahim</strong></a> <br>Professor, Department of Biochemistry & Biotechnology <br>Kagoshima University, Japan </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Hisham R. Ibrahim is currently a Professor of Biochemistry and Structural Biology at Kagoshima University (Japan). He obtained his Master degree in Biochemistry from Yamaguchi University (Japan) in 1990, and PhD degree in Structural Biology and Protein Engineering from Tottori University (Japan) in 1993. He then become a Research Group Leader in Taiyo Kagaku Research Center (Mie, Japan) and carried out research on developing immune molecules against infectious diseases. In 1995, he became Assistant Professor at Kagoshima University, and pursued a research fellowship in the Center for Antimicrobial Research (CAR), California State Polytech University, Los Angeles (USA). He was appointed as Associate Professor in 2001, and become a Professor of Structural Biology at the Department of Biochemistry & Biotechnology in 2010. He is a Conference Developing Member and Chairman in the American Chemical Society (ACS) as well as in the American Oil Chemists Society (AOCS), and serves as reviewer in over 12 reputable journal of biological chemistry, drug design and drug delivery." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="The research focuses on the discovery and design of bio-active peptides and proteins with therapeutic potential for the treatment of infectious diseases, cancers, inflammation and oxidative stress related diseases. The work involves uncovering the molecular mechanisms of bio-active proteins and peptides as a means of developing novel therapeutics and biomedical applications. Other research focus relates mainly to the development of novel drug-delivery system for specific targeting of water-insoluble drugs into their intracellular targets or intracellular infective pathogens by utilizing physicochemical and biological properties of proteins and peptides. A research with a view to explore a novel therapeutic potential of bio-active polypeptides as novel drug targeting molecule for the treatment of complicated human diseases." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--noritaka-kawada-9745.jpg" alt="Noritaka Kawada" title="Noritaka Kawada" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/noritaka-kawada-4600" title="Click here"><strong>Noritaka Kawada</strong></a> <br>Department of Geriatric Medicine and Nephrology <br>Osaka University Graduate School of Medicine, Japan </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Noritaka Kawada did his MD in Osaka University School of Medicine, Japan in 1992, and has received his PhD in Osaka University Graduate School of Medicine, Japan in 1999. He was a Research Assistant Professor in Center for Hypertension and Renal Disease Research, Georgetown University, USA from 2003 to 2006. Currently, he is an Assistant Professor in Osaka University Graduate School of Medicine, Japan." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Kidney disease, Hemodialysis, and renal transplantation. The pathological role of hyperuricemia. Intervention of tissue fibrosis and inflammation. Renal physiology, including renal hemodynamic and electrolyte transport, Hypertension, related to renin-angiotensin system and prostaglandins." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--deepak-bhatia-10876.jpg" alt="Deepak Bhatia" title="Deepak Bhatia" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/deepak-bhatia-4610" title="Click here"><strong>Deepak Bhatia</strong></a> <br>Department of Pharmaceutical Sciences <br>Northeast Ohio Medical University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Deepak Bhatia, Ph.D. is an Assistant professor in the department of pharmaceutical sciences at Northeast Ohio Medical University and an adjunct professor in the School of Biomedical Sciences at Kent State University. Dr. Bhatia received his M.S. and Ph.D. in pharmaceutical and pharmacological sciences from West Virginia University followed by post-doctoral fellowship from City of Hope in the department of stem cells and leukemia research. During his Ph.D. he received fellowship form National Institute of Occupational Safety and Health (NIOSH). His current research is in the area of DNA damage signaling and chemoprevention. He serves as an ad-hoc reviewer for many journals and as editorial board member of international journal of pharmaceutical engineering. Dr. Bhatia also serves as an onsite evaluator for Higher Learning Commission." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="The broad focus of my research is to investigate genetics and epigenetics changes in human lung cancer in response to genotoxic stress. Occupational exposure to mammalian cells elicit a variety of stress-related signals that lead to the altered expression of multiple genes involved in cell-cycle control, programmed cell death, and in some case DNA repair. Interestingly, key growth-control genes, such as the tumor suppressors p53 and RB and transcription factors such as Egr-1, Nf-kB, play central roles in some of these signaling pathways, and perturbations in their function in many human tumor cells have important implications in carcinogenesis. More interestingly, micro RNAs are also suggested to be involved in the regulating these genes that may act as oncogenic or tumor suppressor gene. Therefore, we aim to understand their function upon stress and ultimately use such genes and gene products as molecular genetic tools to employ novel "gene therapy" for the treatment of malignancies notably lung cancer. •Genetic and epigenetic changes in lung cancer upon genotoxic stress – microRNA regulation, cell cycle check points, histone methylation •Chemo-preventive mechanism of dietary agents •Free Radical Biology - Role of reactive oxygen and nitrogen species in cancer •Drug Delivery- functionalized nanoparticles and liposomes drug carriers for siRNA and miRNAs" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--john-l-zhou-8811.jpg" alt="John L Zhou" title="John L Zhou" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/john-l-zhou-4586" title="Click here"><strong>John L Zhou</strong></a> <br>Professor, Department of Applied Sciences <br>London South Bank University, UK </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="John L. Zhou, Professor, Department of Applied Sciences, London South Bank University, UK. Since obtaining his 1st degree in environmental engineering in 1986, John Zhou has been pursuing his research in the UK with a master and PhD degree at Manchester University. He has taught at the University of Wales Bangor and University of Sussex, before becoming Professor of Environmental Engineering at London South Bank University in 2010. He has published over 80 articles in international journals, and acted as an expert assessor for various funding bodies including the EU’s framework programmes and the US National Science Foundation." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Biogeochemistry and ecotoxicology of organic contaminants in natural environment, Environmental analytical chemistry involving novel method development and applications, Characterisation of natural waters and particles and their relation to contaminant fate, Water and wastewater treatment by physical, chemical and biological processes, Production, transport and impact of atmospheric pollutants, Contaminated land and sediments." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--partha-p-banerjee-10541.jpg" alt="Partha P Banerjee" title="Partha P Banerjee" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/partha-p-banerjee-4608" title="Click here"><strong>Partha P Banerjee</strong></a> <br>Associate Professor, Department of Biochemistry and Molecular & Cellular Biology <br>Georgetown University Medical Center, Washington, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Partha Banerjee is an Associate Professor in the Department of Biochemistry and Molecular & Cellular Biology and Member of Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington DC. He received B. Sc. in Zoology Honors from the University of Calcutta, India; M. Sc. in Life-Science and Ph. D. in Endocrine Biochemistry from Visva-Bharati University, Santiniketan, India. Dr. Banerjee did his postdoctoral training from Johns Hopkins University, Baltimore, USA. He is a recipient of visiting scientist fellowship from the National Science Council, Government of Taiwan, American Federation of Aging Research Award, Department of Defense New Investigator Award and several NIH R01 awards. He serves as an Associate Editor of Journal of Carcinogenesis, and editorial board members of The Open Prostate Cancer Journal, World Journal of Clinical Oncology, Journal of Cancer Research & Therapy. He serves as a scientific reviewer for DOD and NIH study sections and reviewers for 25 leading cancer journals. His research focuses on an epigenetically silenced tumor suppressor gene, RASSF1A, regulation of androgen receptor signaling and non-canonical function of telomerase reverse transcriptase in prostate cancer." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="His research focuses on an epigenetically silenced tumor suppressor gene, RASSF1A, regulation of androgen receptor signaling and non-canonical function of telomerase reverse transcriptase in prostate cancer." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--apollina-goel-8851.jpg" alt="Apollina Goel" title="Apollina Goel" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/apollina-goel-4599" title="Click here"><strong>Apollina Goel</strong></a> <br>Department of Radiation Oncology <br>University of Iowa, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Goel is currently an Assistant Professor in the Free Radical and Radiation Biology Program within the Department of Radiation Oncology at the University of Iowa, USA. Dr. Goel received her undergraduate degree in Biotechnology from Pune University, India. She pursued her doctorate in Biotechnology at Institute of Microbial Technology, India. Dr. Goel then undertook post-doctoral studies at University of Nebraska Medical center and at Mayo Clinic, USA. During her postdoctoral research at UNMC, she developed a radioimmunotherapy approach to the treatment of solid tumors. Subsequently she spent two years at Mayo Clinic studying the interactions between genes and transcription factors. During her next two years at Mayo clinic, Dr. Goel combined her basic and translational experience in multiple myeloma and non-Hodgkins lymphoma models. Dr. Goel is currently pursuing targeted radiotherapy (using bone-seeking radiotherapy and oncolytic viruses encoding for human sodium iodide symporter gene) with molecular drugs to target these B-cell malignancies. Dr. Goel has published more than 25 papers in reputed journals, and authored several review articles and book chapters. She is serving as grant reviewer for several agencies and scientific reviewer for several journals." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Chemo-radiotherapy for hematological malignancies, Understanding and circumventing resistance to radiotherapy in multiple myeloma and B-cell lymphoma." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--sidharth-chopra-8832.jpg" alt="Sidharth Chopra" title="Sidharth Chopra" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/sidharth-chopra-4598" title="Click here"><strong>Sidharth Chopra</strong></a> <br>Centre for Infectious Disease and Biodefense Research, Stanford Research Institute International <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Sidharth Chopra is a Research Scientist in Center for Infectious disease and Biodefense Research at SRI International (2008-present). He was a Stanford University Medical Centre post-doctoral fellow (2004-08) where he received a Novozymes fellowship to conduct research in drug discovery for MDR tuberculosis. He worked with Prof. Anand Ranganathan at International Center for Genetic Engineering and Biotechnology (ICGEB) from 2000-04 for pursuing his doctoral degree in Microbial Biotechnology. He has received B.S and M.S. in Microbiology from University of Delhi, India. He is the recipient of CSIR-UGC fellowship to pursue doctoral studies at ICGEB. He regularly reviews articles from Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy among others." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Tuberculosis, Nontuberculous mycobacteria, Staphylococcus, Acinetobacter baumannii, Drug resistance and novel drug discovery." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--alfredo-e-rodriguez-8794.jpg" alt="Alfredo E Rodriguez" title="Alfredo E Rodriguez" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/alfredo-e-rodriguez-4576" title="Click here"><strong>Alfredo E Rodriguez</strong></a> <br>Director, Head Cardiac Unit, Otamendi Hospital <br>Buenos Aires, Argentina </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Alfredo E. Rodriguez, MD, PhD, Cardiovascular Research Centre (CECI), Head of Cardiology Department at Otamendi Hospital, Argentina. He presented at an international breakfast symposium that was dedicated to current experiences with drug-eluting balloons (DEB)." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Diabetes Cardiology Hemodynamics" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/josep-m-argils-4587.jpg" alt="Josep M Argil脙漏s" title="Josep M Argil脙漏s" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/josep-m-argils-4587" title="Click here"><strong>Josep M Argil脙漏s</strong></a> <br>Professor, Department of Biochemistry & Molecular Biology of Cancer <br>University of Barcelona, Spain </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Josep M. Argilés obtained his Doctorate from the University of Barcelona in 1981. He then became Lecturer in Biochemistry and carried out postdoctoral work on acetone metabolism in mammals. In 1987 he undertook further postdoctoral training in the Laboratory of Metabolism and Molecular Biology at the National Institutes of Health, Bethesda, Maryland. in 1988, he became interested in the modulation of the host response by and went to the Metabolic Research Laboratory, radcliffe Infirmary, Oxford, UK to work on the metabolic effects of tumour necrosis factor and other cytokines. At present he is Professor of Biochemistry and Molecular biology at the Faculty of Biology, University of Barcelona, Spain being the leader of a research group interested in cancer cachexia." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Cancer cachexia" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--ngai-sai-ming--10371.jpg" alt="Ngai Sai Ming" title="Ngai Sai Ming" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/ngai-sai-ming-4604" title="Click here"><strong>Ngai Sai Ming</strong></a> <br>Professor, Department of Biology, School of Life Sciences <br>The Chinese University of Hong Kong, Hong Kong </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Professor NGAI Sai Ming is presently working in Department of Biology; Molecular Biotehnology; Cell and Molecular Biology Program.He recieved his PhD from University of Alberta, Canada in 1994.In 1986, he did his B.Sc. (Hons) in Biochemistry from University of Waterloo, Canada.He has worked as and Associate Professor for School of Life Sciences.He also worked as Director for The Chinese Medicinal Fungal Proteomics Laboratory, CUHK and as an Investigator, State Key Laboratory for Agrobiotechnology, CUHK." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Bioinformatics and Proteomics Protein/peptide structural and functional studies Research and development on Modern Chinese Medicine" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--chi-chiu-mok-8829.jpg" alt="Chi-Chiu Mok" title="Chi-Chiu Mok" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/chichiu-mok-4595" title="Click here"><strong>Chi-Chiu Mok</strong></a> <br>Department of Medicine, Tuen Mun Hospital <br>Hong Kong </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Mok is the Chief of Rheumatology in the Department of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. He is also the President of the Hong Kong Society of Rheumatology. Dr. Mok is the principal investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus, rheumatoid arthritis and glucocorticoid-induced osteoporosis. In addition, Dr. Mok is the core editorial member of a number of international journals in Rheumatology and is the adhoc reviewer of more than 50 Rheumatology and General Medical Journals. He has reviewed more than 279 clinical papers and 6 grant applications." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Systemic lupus erythematosus in particular lupus nephritis, Rheumatology, Nephrolog, Diagnosis and management of various rheumatic diseases." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--gamal-abdul-hamid-al-alawi--10321.jpg" alt="Gamal Abdul Hamid Al-Alawi" title="Gamal Abdul Hamid Al-Alawi" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/gamal-abdul-hamid-alalawi-4602" title="Click here"><strong>Gamal Abdul Hamid Al-Alawi</strong></a> <br>Associate Professor, Department of Hematology/Oncology, Faculty of Medicine <br>University of Aden, Yemen </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Prof Dr med Gamal Abdul Hamid has received his PhD in hematology-oncology from faculty of medicine (Caral Gustav Carus),University of Dresden during the period of 1988- 1993. Currently , he is working as director of Aden Oncology Center and head of hematology and clinical laboratory in Faculty of Medicine, University of Aden. He has successfully completed his administrative responsibilities as general secretary of Yemen Cancer Society and founder of Aden cancer registry. He is serving as an editorial member of several journals like Yemen Oncology newsletter, Journal of pathobiology and toxicology. He has authored or co-authored many articles in a great variety of journals and has delivered lectures at many conferences and institutions in Yemen and internationally and referee for national and international journals. He is member of ESMO, ASCO, INCTR and Panarab Oncology." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Leukemia - lymphoma Gastrointestinal cancers" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--terry-lichtor-10936.JPG" alt="Terry Lichtor" title="Terry Lichtor" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/terry-lichtor-4611" title="Click here"><strong>Terry Lichtor</strong></a> <br>Associate Professor, Department of Neurological Surgery <br>Rush University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Prof.Terry Lichtor has received his PhD in University of Chicago during the period of 1980.Currently,he is working as Associate Professor in Rush University,USA.He is serving as an editorial member of several reputed journals like American Journal of Medical and Biological Research and World Journal of Immunology. He has authored 63 research articles and 2 books. He is a member of American Medical Association. He has honored as America’s Top Surgeon." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Gene Therapy Strategies in the Treatment of Brain Tumors Development of Brain Tumor Vaccines Development of MRI Technology for Measurement of Intracranial Pressure Molecular Strategies in the Treatment of Alzheimer’s Disease" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--mirko-omejc-10940.JPG" alt="Mirko Omejc" title="Mirko Omejc" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/mirko-omejc-4612" title="Click here"><strong>Mirko Omejc</strong></a> <br>Professor, Department of Abdominal Surgery <br>University of Ljubljana, Slovenia </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr.Mirko Omejc has received his PhD in University of Ljubljana during the period of 1996. Currently, he is working as Head of Department for Abdominal Surgery in University of Ljubljana, Slovenia. He has successfully completed his Administrative responsibilities as Professor of Surgery, Medical Faculty, University of Ljubljana." data-original-title=""> Biography </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--manuela-stoicescu-10942.jpg" alt="Manuela Stoicescu" title="Manuela Stoicescu" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/manuela-stoicescu-4613" title="Click here"><strong>Manuela Stoicescu</strong></a> <br>Department of Medical Disciplines <br>University of Oradea, Romania </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Internal Medicine, Cardiology, High blood pressure." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--remigius-u-agu-11203.jpg" alt="Remigius U Agu" title="Remigius U Agu" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/remigius-u-agu-4614" title="Click here"><strong>Remigius U Agu</strong></a> <br>Associate Professor, Pharmaceutics and Biopharmaceutics <br>Dalhousie University, Canada </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Remigius U. Agu was a practicing pharmacist before joining the academia. He has a Masters degree in Pharmacology (University of Nigeria) and Biopharmaceutics (University of Leuven, Belgium), respectively. He also has a PhD in Pharmaceutics and Biopharmaceutics from the University of Leuven, Belgium. As a scientist, Dr. Agu worked in Africa, Europe and USA before joining Dalhousie University in 2004. Currently, he is an Associate Professor of Pharmaceutics and Biopharmaceutics at the College of Pharmacy. Dr. Agu is also cross-appointed to the Department of Surgery, Dalhousie University, Halifax, Nova Scotia. He is involved in many basic science and clinical research in the areas of nasal/pulmonary drug delivery and pain management. Dr. Agu’s core research involves the development of novel respiratory drug delivery systems and testing methods. Dr. Agu is currently an editorial board member of two international journals and frequently reviews articles for more than twenty-top ranking pharmaceutical journals" data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="He is involved in many basic science and clinical research in the areas of nasal/pulmonary drug delivery and pain management. Dr. Agu’s core research involves the development of novel respiratory drug delivery systems and testing methods." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--zhe-sheng-chen-11265.jpg" alt="Zhe Sheng Chan" title="Zhe Sheng Chan" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/zhe-sheng-chan-4615" title="Click here"><strong>Zhe Sheng Chan</strong></a> <br>Professor, Department of Pharmaceutical Sciences <br>St. John’s University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Zhe-Sheng (Jason) Chen, M.D., PhD, is currently a Professor and a Director of Cancer Pharmacology Laboratory at College of Pharmacy and Health Sciences, St. John’s University. He joined St. John’s University in 2004 as an assistant professor. Since 2008, he established several research projects to study ABC transporters and multidrug resistance (MDR) as well as reversal of MDR in both in vitro and in vivo tumor models. During past 8 years, his laboratory has been well funded by NIH and Companies. He published more than 100 peer-reviewed research articles and 2 book chapters. He carried out his postdoctoral training at Fox Chase Cancer Center (Philadelphia, USA, 2000-2004) and Kagoshima University Faculty of Medicine (Japan, 1998-2000). He received his Ph.D. degree from Kagoshima University Faculty of Medicine (Japan, 1994-1998), Master degree from Sun Yat-Sen University School of Public Health (China, 1985-1988) and M.D. from Guangdong Medical and Pharmaceutical College (China, 1980-1985)." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Physiology, Pharmacology and Pathology of ATP-binding cassette (ABC) transporters; Cellular and Molecular Mechanisms of multidrug resistance. Chen laboratory is interested in the molecular and cellular pharmacology of anticancer drugs, such as drug resistance mechanisms and reversal of resistance study and new drug development. A promise of our research program is that progress in the chemotherapy of cancer will depend on rational combination of agents that reduce the function of plasma membrane transporters such as P-gp, ABCG2 and MRPs, and to enhance the actions of cytotoxic drugs. In collaboration with many researchers in USA, China, Japan, Canada, Australia and Egypt, studies in Chen’s laboratory focus on screening and identifying new inhibitors of ABC transporters by in vitro membrane vesicles transport assay system and cell based assay systems. Another research direction is to study the role of ABC transporters family on the detoxification of chemicals (including carcinogens and mutagens) using knock out mouse models." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--kathleen-a-packard-11267.jpg" alt="Kathleen A Packard" title="Kathleen A Packard" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/kathleen-a-packard-4616" title="Click here"><strong>Kathleen A Packard</strong></a> <br>Associate Professor, Department of Pharmacy Practice <br>Creighton University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Packard received her Doctor of Pharmacy and Masters in Pharmaceutical Sciences degrees from Creighton University in 2001. She completed a post-doctoral fellowship in cardiovascular research at the Cardiac Center of Creighton University in Omaha, Nebraska. Dr. Packard joined the Nebraska Heart Institute in 2003 as Director of Research. In 2007, she returned to Creighton University as faculty in the department of Pharmacy Practice. Dr. Packard provides inpatient clinical pharmacy services to patients in the cardiac unit at the Bryan Health Medical Center East and outpatient services at the cardiac rehabilitation clinic at Bryan Health LifePointe. She currently teaches cardiovascular pharmacotherapy to pharmacy students and conducts research in many areas of cardiovascular therapeutics, primary prevention and related pedagogy." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="She currently teaches cardiovascular pharmacotherapy to pharmacy students and conducts research in many areas of cardiovascular therapeutics, primary prevention and related pedagogy." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--zara-risoldi-cochrane-11271.jpg" alt="Zara Risoldi Cochrane" title="Zara Risoldi Cochrane" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/zara-risoldi-cochrane-4617" title="Click here"><strong>Zara Risoldi Cochrane</strong></a> <br>Assistant Professor, Department of Pharmacy Practice <br>Creighton University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Risoldi Cochrane earned her Doctorate of Pharmacy from Shenandoah University’s Bernard J. Dunn School of Pharmacy in 2008. She completed a specialty residency in drug information at the Creighton University Center for Drug Information and Evidence-Based Practice in Omaha, NE. Since then, Dr. Risoldi Cochrane has chosen to remain at Creighton University School of Pharmacy and Health Professions as a Drug Information Specialist and Assistant Professor of Pharmacy Practice. In addition to teaching didactic and experiential pharmacycourses, Dr. Risoldi Cochrane serves as formulary liaison to Creighton University Medical Center and provides full Pharmacy & Therapeutics Committee support. Additionally, she precepts the longitudinal drug information experience for the postgraduate pharmacy residents at Creighton University Medical Center, Creighton University Clinic Pharmacy, and Bergan Mercy Medical Center. An advocate for global health, Dr. Risoldi Cochrane has participated in several international medical missions and has been nationallyrecognized for her volunteer service." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Risoldi Cochrane’s areas of interest have included drug literature evaluation, evidence-based medicine, health literacy and health communication. She has published research in several peer-reviewed journals, including the Journal of Health Communication, Journal of Evidence-Based Complementary and Alternative Medicine, Journal of Dietary Supplements, and Translational Andrology and Urology" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--leanne-l-lai-11275.JPG" alt="Leanne L Lai" title="Leanne L Lai" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/leanne-l-lai-4618" title="Click here"><strong>Leanne L Lai</strong></a> <br>Professor, Department of sociobehavioural Administrative Pharmacy <br>Nova Southeastern University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Professor Leanne L Lai has received her PhD in University of Maryland during the period of 1996. Currently, she is working as Professor in Nova Southeastern University, USA. She has successfully completed her Administrative responsibilities as Director of International Pharmacy Program- Nova Southeastern University, College of Pharmacy (2002- 2011). She is serving as an editorial member of several reputed journals like Journal of Managed Pharmaceutical Care. She has authored 108 research articles and published 24 scientific articles. She is a member of Pharmaceutical and Therapeutic Committee – State of Florida (2001 - 2007) and Drug Utilization Review Board – State of Florida (1998-2010)." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="• Pharmacoeocnomics and Outcome Research • Pharmacoepidemiology and Secondary Data Analysis • International Education" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--michael-a-gillette-11277.JPG" alt="Michael A Gillette" title="Michael A Gillette" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/michael-a-gillette-4620" title="Click here"><strong>Michael A Gillette</strong></a> <br>Assistant Professor, Department of Pharmacy Practice <br>Nova Southeastern University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Michael A. Gillette is a pharmacist researcher in the area of cardiovascular diseases. He graduated from Nova Southeastern University and completed his post-graduate training in cardiology with the Department of Veterans Affairs in affiliation with the University of Florida. He has been appointed as an assistant professor at his alumni, Nova Southeastern University College of Pharmacy, and continues to contribute to primary research in the area of cardiovascular diseases. He has been a reviewer for high impact pharmacology journals such as Pharmacotherapy, Annals of Pharmacotherapy, Hospital Pharmacy and Journal of Health System Pharmacy Residents." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Cardiovascular Diseases Outcomes Research Meta-Analysis Geriatric Medicine" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--hamid-omidian-11278.jpg" alt="Hamid Omidian" title="Hamid Omidian" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/hamid-omidian-4621" title="Click here"><strong>Hamid Omidian</strong></a> <br>Associate Professor, Department of Pharmaceutical Sciences <br>Nova Southeastern University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Omidian (Ph.D. in chemical engineering, polymer science), served in both academia and industry for about 23 years. He joined Purdue University in 2001, and pursued his research fellowship in the department of industrial and physical pharmacy. He joined industry in 2002 and served at different professional positions at Kos Pharmaceuticals and Abbott Laboratories. Dr. Omidian has over 120 peer-reviewed publications and presentations, author and co-author of dozens book chapters and books, and holding 3 US patents and over 10 US and world patent applications. He is currently serving as an associate professor at Nova Southeastern University’s college of pharmacy, and as an associate editor and editorial board member of several journals. He is also recipient of many research and teaching awards, including Golden Apple in Teaching. His major research areas are hydrogels for pharmaceutical and biomedical applications, gastric retention drug delivery and abuse-deterrent pharmaceutical dosage forms." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="His major research areas are hydrogels for pharmaceutical and biomedical applications, gastric retention drug delivery and abuse-deterrent pharmaceutical dosage forms." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--karen-falck-marlowe-11279.jpg" alt="Karen Falck Marlowe" title="Karen Falck Marlowe" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/karen-falck-marlowe-4622" title="Click here"><strong>Karen Falck Marlowe</strong></a> <br>Associate Department Head, Department of Pharmacy Practice <br>Auburn University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Karen F. Marlowe, Pharm D, BCPS,CPE–After graduating from Auburn University, Karen completed her pharmacy practice residency at Children’s Healthcare of Atlanta.In 2000, sheaccepted an appointment with Auburn University with a practice affiliated with the University of South Alabama Medical School, Department of Internal Medicine. Sheprovidespharmacotherapy consults forinpatient internal medicine patients, and also maintains a consult service for pain management and end of life care. This unique consult service is based on providing advocacy to patients and care providers to increase access to appropriate pain management and symptom management.Her research interests revolve around the attitudes/perceptions of practitioners regarding chronic pain patients and how their beliefsimpact the care these patients receive. She is also pursuing information related to opioids and how they impact the care of chronic pain patients. For the last three years, shehas served as the Assistant Dean of the Mobile Satellite Campus for the Harrison School of Pharmacy as well as the Associate Department Head for the Department of Pharmacy Practice." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Her research interests revolve around the attitudes/perceptions of practitioners regarding chronic pain patients and how their beliefsimpact the care these patients receive. She is also pursuing information related to opioids and how they impact the care of chronic pain patients." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--harsh-chauhan-11280.jpg" alt="Harsh Chauhan" title="Harsh Chauhan" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/harsh-chauhan-4623" title="Click here"><strong>Harsh Chauhan</strong></a> <br>Assistant Professor, Department of Pharmacy Sciences <br>Creighton University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Harsh Chauhan is an Assistant Professor at Creighton University,Omaha, NE. Dr. Chauhan received his Ph.D. in Pharmaceutics from MCPHS,Boston, MA. His research emphasizes on amorphous systems and solid lipidnanoparticles. He worked as visiting scientist at Vertex pharmaceuticalsand his professional affiliations include AAPS, ACS and AACP." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Research and educational interest includes Pharmaceutical drug delivery systems, drug toxicity, drug resistance, role of meditation in healthy lifestyle, behavioral and psychological issues associated with medication." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--rais-a-ansari-11285.JPG" alt="Rais A Ansari" title="Rais A Ansari" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/rais-a-ansari-4624" title="Click here"><strong>Rais A Ansari</strong></a> <br>Assistant Professor, Department of Pharmaceutical Sciences <br>Nova Southeastern University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Professor Rais A Ansari has received his PhD in Kanpur University, India during the period of 1980-1985. Currently, he is working as Assistant Professor in Nova Southeastern University, USA. He has successfully completed his Administrative responsibilities as Adjunct Professor, Kent State University,USA. He is serving as an editorial member of several reputed journals like American Journal of Biochemistry and Drug Intoxication and Detoxification: Novel Approaches. He has authored 60 research articles and one book. He is a full member for Society of Toxicology since 1993." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="1. Regulation of human angiotensinogen gene by xenobiotics and its role in hepatotoxicity and hypertension. 2. Mechanism of Hepatosteatosis after Xenobiotics: Role of Transport Process. 3. Role of transport protein(s) variants in drug toxicity and safety. 4. Establishment of viral/eukaryotic/mammalian expression systems for expression and purification of recombinant proteins for drug discovery." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--liqin-zhao-11303.jpg" alt="Liqin Zhao" title="Liqin Zhao" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/liqin-zhao-4625" title="Click here"><strong>Liqin Zhao</strong></a> <br>Associate Professor, Pharmacology & Pharmaceutical Sciences <br>University of Southern California, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Zhao received her Ph.D. in Pharmaceutical Sciences from Shenyang Pharmaceutical University in China in 1999. She continued her postdoctoral research in neuroscience at the Beijing Institute of Pharmacology and Toxicology, where she was awarded two prestigious grants on neurodegenerative disease drug discovery from the China Postdoctoral Research Foundation and the National Natural Science Foundation of China. Dr. Zhao joined the University of Southern California (USC) in 2002 and is now a Research Associate Professor of Pharmacology and Pharmaceutical Sciences in the School of Pharmacy. Dr. Zhao has served as a PI/Co-PI on multiple funded projects including two investigator-initiated grants from the Alzheimer’s Association, one clinical trial (R01) and two program project (P01) grants from the National Institute on Aging. She has authored nearly 50 peer-reviewed research articles, 50 conference presentations, 5 patents, and served as an editor/reviewer for over 30 medical research journals." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Two-level interdisciplinary research on neuroendocrine aging and neurodegeneration (with an emphasis on Alzheimer’s disease; AD) aims: 1. At the basic level, to understand the neurobiological effects of sex hormones and the molecular basis underlying sex differences in the risk of developing AD. Some particular areas of interest include menopause/perimenopause, insulin/IGF signaling, cellular bioenergetics, amyloid metabolism, apolipoproteins, and gene expression and regulation. 2. At the translational level, to advance basic scientific findings into therapeutic development for prevention and early intervention of age-related conditions and neurodegeneration. Some particular areas of focus include non-hormonal alternative therapies, estrogen receptor betaselective modulators, phytochemicals, and lifestyles in modulation of aging." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--robert-a-lodder-11304.jpg" alt="Robert A Lodder" title="Robert A Lodder" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/robert-a-lodder-4626" title="Click here"><strong>Robert A Lodder</strong></a> <br>Professor, Department of Pharmaceutical Sciences <br>University of Kentucky, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Robert Lodder is a Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky Medical Center, where he joined the faculty in 1988. He is also President of Spherix Incorporated. Dr. Lodder holds joint appointments as a professor in the Department of Electrical and Computer Engineering, and in the Department of Chemistry at Kentucky (Division of Analytical Chemistry). Dr. Lodder has over a dozen awarded patents, ten additional pending patent applications, and has founded three other venture-funded companies based on products of his research. Dr. Lodder was appointed as an SGE by the U.S. Food and Drug Administration. Dr. Lodder publications and projects have spanned pharmaceutical, preclinical and clinical uses. patented 5 new drugs that have been licensed to the pharmaceutical industry. As an analytical chemist, he has also converted a score of techniques to PAT use. Using data developed from these projects, Dr. Lodder has conducted mathematical studies aimed at solving the "false-sample" problem in thought-like operations on parallel processors and clouds. The cloud concepts have been extended to analytical instrumentation itself in the form of systems for magnetohydrodynamic acoustic-resonance near-infrared spectrometry (MAReNIR). Dr. Lodder is author of 110 publications and over 300 presentations. Dr. Lodder was first-prize winner in the 1990 international IBM Supercomputing Competition, as well as a winner of a National Science Foundation Young Investigator Award, the American Society of Agricultural Engineers Paper Award, a Buchi NIR Award, the Tomas Hirschfeld Award in Near-IR Spectroscopy (PittCon), and a Research and Development 100 Award." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="As an analytical chemist, he has also converted a score of techniques to PAT use. Using data developed from these projects, Dr. Lodder has conducted mathematical studies aimed at solving the "false-sample" problem in thought-like operations on parallel processors and clouds. The cloud concepts have been extended to analytical instrumentation itself in the form of systems for magnetohydrodynamic acoustic-resonance near-infrared spectrometry (MAReNIR)." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--bodhisattwa-chaudhuri-11308.jpg" alt="Bodhisattwa Chaudhuri" title="Bodhisattwa Chaudhuri" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/bodhisattwa-chaudhuri-4627" title="Click here"><strong>Bodhisattwa Chaudhuri</strong></a> <br>Assistant Professor, Department of Pharmaceutical Sciences <br>University of Connecticut, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Chaudhuri holds Assistant Professor position in the Department of Pharmaceutical Sciences at the University of Connecticut. He got his BS and MS in Chemical Engineering from Jadavpur University, Calcutta and Indian Institute of Science, Bangalore respectively. Thereafter, he got his PhD in Mechanical Engineering from New Jersey Insititute of Technology and worked in the telecommunication industry for 3 years. He joined University of Connecticut as as Assistant Professor in Pharmaceutical Technology after 4 years of postdoctoral research in Department of Chemical Engineering and NSF-Engineering Research Center in Rutgers University. He has given 6 invited talks and the author of more than 50 book chapters, journal publications and conference proceedings. He currently serves in the Editorial board of several journals and in the advisory committees of multinational companies and international conferences. Dr. Chaudhuris research on Pharmaceutical Technology is supported by FDA, NIH, PhRMA Foundation, Pfizer, Boehringer Ingelhiem and CPPR." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="My general research area is experimentally validated high performance scientific computing, particularly in the areas of multi-scale modeling of complex fluid, materials, biological systems and nano-pharmaceuticals." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--frank-m-etzler-11314.jpg" alt="Frank M Etzler" title="Frank M Etzler" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/frank-m-etzler-4629" title="Click here"><strong>Frank M Etzler</strong></a> <br>Associate Professor, Department of Pharmaceutical Sciences <br>Lake Erie College of Osteopathic Medicine, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Etzler earned a Ph.D. in physical chemistry from the University of Miami. He is currently an Associate Professor of Pharmaceutics in the School of Pharmacy at the Lake Erie College of Osteopathic Medicine (LECOM). Prior to coming to LECOM in 2011, he was the leader of the Material Science Laboratory at Boehringer-Ingelheim Pharmaceuticals for nearly 20 years. This laboratory was responsible for the physical characterization of powders. Dr. Etzler was involved with the development of Spriva. Prior to this, Dr. Etzler was a faculty member in pharmaceutics at the University of Kentucky and a faculty member in surface and colloid science at the former Institute of Paper Chemistry." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Pharmaceutics - Pulmonary Formulation, Solids Formulation, Preformulation. Adhesion Science Particle Size Analysis Mechanical Properties of Solids Powder Compaction Powder Flow" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--ronald-r-burnette-11326.jpg" alt="Ronald R Burnette" title="Ronald R Burnette" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/ronald-r-burnette-4630" title="Click here"><strong>Ronald R Burnette</strong></a> <br>Professor, Department of Pharmaceutical Sciences <br>University of Wisconsin-Madison, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Ron received his B.S. degree (1971) in electrical engineering from the University of California-Irvine, M.S. degree (1973) in electrical engineering from Stanford University, and Pharm.D. (1979) and Ph.D. (1982) degrees in pharmaceutical chemistry from the University of California-San Francisco. He joined the Wisconsin faculty in 1982." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="At the whole organism level (animal and human), our research group is interested in developing computer algorithms, using the principles obtained from pharmacokinetics, pharmacodynamics and pharmacogenomics, in order to optimize drug delivery and to understand drug interactions.        At the molecular level, the basic premise underlying our research is that one can combine experimental data, such as that obtained from spectroscopic techniques and X-ray crystallography, in a synergistic manner with computational chemistry to determine molecular structure and to understand intermolecular and intramolecular interactions. This, in turn, provides the basis for beginning to understand drug delivery systems at a more fundamental level. More precisely these investigations provide a mechanism by which one can start to predict how specific molecular changes will alter a drug delivery system at both the structural and energetic level." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--taimour-langaee-11327.jpg" alt="Taimour Langaee" title="Taimour Langaee" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/taimour-langaee-4631" title="Click here"><strong>Taimour Langaee</strong></a> <br>Associate Professor, Department of Pharmacotherapy and Translational Research <br>University of Florida, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Taimour Y. Langaee, MSPH, Ph.D., is Research Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Langaee's research interests are focused on pharmacogenomics (genetic-based variability in drug response) in cardiovascular disease; pharmacogenomics of anticoagulants (Warfarin); Pharmacogenetics of Dichloroacetate(DCA); Clinical, Geneticsand Microbial Interactions in Inflammatory Bowel Disease (IBD); Microbial resistance to antibiotics." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--deepak-gupta-11329.jpg" alt="Deepak Gupta" title="Deepak Gupta" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/deepak-gupta-4632" title="Click here"><strong>Deepak Gupta</strong></a> <br>Assistant Professor, Department of Pharmaceutical Sciences, Lake Erie College of Osteopathic Medicine <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Gupta obtained his B.Pharmacy from Guru Jambheshwar University, India and his M.S. (Pharmaceutical Sciences) fromPoona College of Pharmacy, India.His project involved synthesis and evaluation of prodrugs of anti-inflammatory and anti-cancer agents. Later, he underwent training at Central Drug Research Institute (CDRI), Lucknow, India in drug design and molecular modeling. His Ph.D. dissertation mainly focused on the design, synthesis and biological evaluation of mechanism based inhibitors targeting malaria. Dr. Gupta later joined University of Michigan (UM) as postdoctoral research fellow under Dr. Gordon Amidon at the Center for Molecular Drug Targeting.At UM, he was involved in the design, synthesis, in-vitro, in-situ and in-vivo evaluation of Influenza drugs and also MRI active contrast agents for diagnosis of solid tumors. He joined LECOM-School of Pharmacy in July 2009 as assistant professor of Pharmaceutical Sciences. He is currently the Director of Center of Drug Delivery and Targeting (CDDT) at LECOM." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="• Drug Design And Development • Drug Delivery (Prodrugs) • Mucosal Transport and Transporters • Drug Metabolism and Activation Pathways" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--grant-h-skrepnek-11330.JPG" alt="Grant H Skrepnek" title="Grant H Skrepnek" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/grant-h-skrepnek-4633" title="Click here"><strong>Grant H Skrepnek</strong></a> <br>Associate Professor, Department of Pharmacy Practice & Science <br>The University of Arizona, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Grant H. Skrepnek, Ph.D., M.Sc., R.Ph., is an Associate Professor with Tenure at The University of Arizona College of Pharmacy. He additionally serves as a Full Investigator within The University of Arizona Cancer Center (UACC), an Affiliate of the Arizona Water Institute, and an Investigator within the Center for Health Outcomes and PharmacoEconomic Research (HOPE), the Arizona Emergency Medicine Research Center (AEMRC), and the Venom Immunochemistry, Pharmacology, and Emergency Response (VIPER) Institute. Dr. Skrepnek received his B.S., M.Sc., and Ph.D. in Pharmacy at The University of Texas at Austin, where he conducted research on the industrial economics of the pharmaceutical industry and completed his minor area studies in both finance and management." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="As faculty at The University of Arizona, Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek has focused on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardio-pulmonary disease, rare conditions, and comorbidities. Furthermore, he is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data. His interests extend to policy issues concerning Medicare and Medicaid, industrial organization economics in the pharmaceutical industry, and financial econometrics. Dr. Skrepnek also studies practice-related aspects of healthcare which include reimbursement, academia, safety, patient compliance and adherence, treatment guideline implementation, disease management, and the use of technology by clinicians. He has received funding from numerous organizations and was a co-investigator within The University of Arizona\'s Center for Education and Research on Therapeutics (CERT) funded by the Agency for Healthcare Research and Quality (AHRQ)." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--james-g-mitroka-11352.jpg" alt="James G Mitroka" title="James G Mitroka" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/james-g-mitroka-4634" title="Click here"><strong>James G Mitroka</strong></a> <br>Associate Professor, Gregory School of Pharmacy <br>Palm Beach Atlantic University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Mitroka earned a B.S. in Chemistry from Michigan State University, and a Ph.D. in Pharmacology and Toxicology from Rutgers University. Prior to joining PBA, he worked for Bristol-Myers Squibb as a research group leader and conducted studies to determine the metabolic fate of experimental drugs. Jim’s experience includes studies involving stable and radioactive isotopes both in vivo and in vitro. Jim left in 2008 BMS to begin teaching at the Palm Beach Atlantic Gregory School of Pharmacy. He teaches medicinal chemistry, pharmacology, and pharmacogenomics. Jim’s research interest includes the use of biomarkers to evaluate the impact of behavioral interventions and natural products on health and disease." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Jim’s research interest includes the use of biomarkers to evaluate the impact of behavioral interventions and natural products on health and disease." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--mutasem-rawas-qalaji-11353.JPG" alt="Mutasem Rawas-Qalaji" title="Mutasem Rawas-Qalaji" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/mutasem-rawasqalaji-4635" title="Click here"><strong>Mutasem Rawas-Qalaji</strong></a> <br>Assistant Professor, Department of Pharmaceutical Sciences <br>Nova Southeastern University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Rawas-Qalaji earned his Ph.D. in Pharmaceutics (2006) from the University of Manitoba, Canada. He received several international, national, provincial, and institutional awards. He was awarded Strategic Training in Allergy Research Award from the American Academy of Allergy, Asthma & Immunology’s, The Canadian Foundation for Pharmacy National Award, Manitoba Health Research Council Award, Manitoba Institute of Child Health Award, Manitoba Pharmaceutical Association Award, and University of Manitoba Fellowship. He joined QLT Inc. (2007) in Vancouver, Canada, as a postdoc in Preclinical Formulation and was awarded Natural Sciences and Engineering Research Council Fellowship. Also, he worked as a formulation scientist for ENWAVE Corp. (2008) in Vancouver, Canada. He joined Nova Southeastern University (2008-present) in Fort Lauderdale, Florida as an Assistant Professor at the College of Pharmacy. He has more than 39 peer-reviewed publications, 37 conference and podium presentations, and 13 patent applications." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="- Pharmaceutical Dosage Form Design and Development - Nanoparticles and nanocrystals fabrication and charcterization - In Vitro / Ex vivo / In vivo Studies - Analytical Analysis - Statistical Analysis" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/micheal-s-guirguis-4636.jpg" alt="Micheal S Guirguis" title="Micheal S Guirguis" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/micheal-s-guirguis-4636" title="Click here"><strong>Micheal S Guirguis</strong></a> <br>Adjunct Professor, Department of Pharmacy and Pharmaceutical Sciences <br>University of Alberta, Canada </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Micheal Guirguis provides scientific and administrative support to the Alberta Health and Wellness Expert Committee on Drug Evaluation and Therapeutics, specifically in the areas of interchangeability and bioequivalence. Previously, Dr. Guirguis worked at Abbott Laboratories and Covance Labs, as a clinical pharmacokineticist supporting the design and analysis of pharmacokinetic studies. In addition Dr. Guirguis is an Adjunct Professor of Pharmacy and Pharmaceutical Sciences at the University of Alberta supporting education and research in Pharmacometrics, and Pharmacokinetics. As well as a Recognized Instruction and Dissertation Advisor at the University of Liverpool/Laureate online based Masters in Clinical Research." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Pharmacometrics and Pharmacokinetics" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--sudip-k-das-11365.jpg" alt="Sudip K Das" title="Sudip K Das" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/sudip-k-das-4637" title="Click here"><strong>Sudip K Das</strong></a> <br>Associate Professor, Department of Pharmaceutics <br>Butler University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Sudip K. Das is the Director of the Graduate Program and Research in Pharmaceutical Sciences and Associate Professor of Pharmaceutics at the College of Pharmacy & Health Sciences, Butler University, Indianapolis, IN, where he also served as the chair of the Department of Pharmaceutical Sciences from 2004-09. Dr. Das has over twenty years of teaching and research experience in the professional pharmacy and graduate programs in the USA and Canada. He has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the revitalization of the graduate program and research infrastructure in pharmaceutical sciences at Butler University. His current research involves targeted delivery of siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases. Dr. Das has over 150 research publications, review articles, US patents, proceedings, conference presentations, and book chapters, is a recipient of multiple awards/honors, and has secured extramural research funding from NIH,PDA,etc., and the pharmaceutical industry. Dr. Das is also an active member of AAPS (since 1991) and CRS (Controlled Release Society, since 1987). He has served on many committees of the PDD/PPB and BIOTEC sections of AAPS. Since 2004, he has served on several study sections on drug delivery and bioengineeringofthe NIH - Center for Scientific Review, and continues to serve on the editorial boards of many reputed journals." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Targeted drug delivery for anticancer drugs and siRNA, nanomedicine, translational research" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--john-m-seubert-11366.jpg" alt="John M Seubert" title="John M Seubert" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/john-m-seubert-4638" title="Click here"><strong>John M Seubert</strong></a> <br>Adjunct Associate Professor, Department of Pharmacology <br>University of Alberta, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Seubert obtained his BSc in biology and MSc in aquatic toxicology with from Simon Fraser University. He received his Doctorate in Pharmacology andToxicology from the Faculty of Medicine at the University of Western Ontario. He went on to complete a fellowship in Cardiovascular Pharmacology at the National Institute of Environmental Health Science in Research Triangle Park, NC, under the supervision of Dr. Darryl Zeldin. Dr. Seubert established his own independent research laboratory in the area of cytochrome P450-dervied metabolites of arachidonic acid health and disease,in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, where he has an adjunct appointment in the Department of Pharmacology. He received a New investigator Award from the Heart and Stroke Foundation of Canada in 2007 and is an Alberta Innovates Health Scholar. He is as an active member of the Cardiovascular Research Centre and the Mazankowski Heart Institute and the Toxicology Research Group at the University of Alberta." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Research in our lab is focused on investigating the cellular role of cytochrome P450-dervied metabolites of arachidonic acid (epoxyeicosatrienoic acids – EETs) in maintaining cellular and tissue homeostasis and reducing injury." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--esther-woon-11367.jpg" alt="Esther Woon" title="Esther Woon" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/esther-woon-4639" title="Click here"><strong>Esther Woon</strong></a> <br>Assistant Professor, Department of Pharmacy <br>National University of Singapore, Singapore </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr Esther Woon received her Ph.D. in Medicinal Chemistry from the University of Bath, Department of Pharmacy in 2004. She then received an AICR postdoctoral fellowship to study the mechanism and inhibition of protein-protein interaction at the UCL School of Pharmacy. In 2008, she was awarded a European Union-funded postdoctoral fellowship to work on epigenetic probe discovery at the University of Oxford, Department of Chemistry, where she contributed to the first report of several highly selective and potent small molecule probes for the histone and nucleic acid demethylases. This work enabled subsequent functional and mechanistic studies on these enzymes. She is currently an Assistant Professor at the Department of Pharmacy, National University of Singapore. She continues to work in the field of epigenetics, and is the leading group in developing dynamic boron chemistry-based methods for rapid probe/ drug discovery." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="1. Development of selective and cell-active probes to study the epigenetic basis for obesity and other metabolic diseases. 2. Applying a combination of crystallographic and other biophysical techniques to understand the mechanism for substrate specificity for the JmjC histone demethylases. 3. Development of Dynamic Combinatorial Chemistry (DCC)-based techniques suitable for the rapid discovery of drugs." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--mohammad-nasir-uddin-11368.JPG" alt="Mohammad Nasir Uddin" title="Mohammad Nasir Uddin" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/mohammad-nasir-uddin-4640" title="Click here"><strong>Mohammad Nasir Uddin</strong></a> <br>Assistant Professor of Pharmacy, Levine College of Health Sciences <br>Wingate University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Mohammad Nasir Uddin is an Assistant Professor in School of Pharmacy at Lake Erie College of Osteopathic Medicine, LECOM. He completed his Bachelor degree in Chemistry from Jahangirnagar University, Dhaka Bangladesh. He received his M. Sc. in Chemistry from Emory University, Atlanta in 2006. He received his Ph.D in Pharmaceutics from Mercer University, Atlanta in 2011. He was also a faculty member at Science department, Georgia Perimeter College, Dunwoody. Georgia. He worked on nano-particle based vaccine development for Human Papillomavirus (HPV) as scientist at CDC in 2010 and 2011. His research has lead to 14 peer reviewed papers and numerous scientific presentations. He is also member of several Professional Organization including Association of American Pharmacy Scientists (AAPS) American Association of Colleges of Pharmacy (AACP), Control Release Society (CRS) American Society of Microbiology (ASM), and American Chemical Society (ACS)" data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="My research interest involves the study of developing vaccines for most prevalent and challenging diseases using micro/nano particle platform based technology. The research mainly focused on development of particulate vaccine against Human Papillomavirus (HPV) for both prophylactic and therapeutic use for cervical cancer. My further research interests include oral formulation development using nano or micro particle for infectious diseases. I am also interested in adhesion and development of nanoparticles for drug delivery purpose." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--robert-a-freeman-11375.jpg" alt="Robert A Freeman" title="Robert A Freeman" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/robert-a-freeman-4641" title="Click here"><strong>Robert A Freeman</strong></a> <br>Professor, Department of Pharmacy Practice & Administration <br>University of Maryland, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Robert Freeman is currently Professor of Pharmacy Administration (health services research) in the Department of Pharmacy Practice & Administration at the University of Maryland Eastern Shore School of Pharmacy. He has over 20 years’ experience in the global pharmaceutical industry having served as a leader of public policy and health economics functions for AstraZeneca and Sanofi among others. Prior to his current academic position he was Professor of Pharmaceutical Sciences and Director of Graduate Studies at the Rangel College of Pharmacy at Texas A&M Health Sciences Center. He is the author of over 75 research and professional publications in comparative effectiveness research, public policy, health economics & outcomes research and pharmaceutical industry finance economics. His current research focuses on policy initiative to incentivize pharmaceutical R&D. He earned his BS in Pharmacy and his MS and PhD degrees from the University of Mississippi." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="His current research focuses on policy initiative to incentivize pharmaceutical R&D." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--cesar-m-compadre-11446.jpg" alt="Cesar M Compadre" title="Cesar M Compadre" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/cesar-m-compadre-4642" title="Click here"><strong>Cesar M Compadre</strong></a> <br>Professor, Department of Pharmaceutical Sciences <br>University of Arkansas Medical Sciences, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Compadre has extensive research experience, on the development of bioactive compounds based on naturally occurring compounds, and on the use of molecular modeling in drug design and structure-activity studies. He has published over papers and over 70patents related to the development of bioactive compounds, and one FDA approved antimicrobial technology. Dr. Compadre has a BSPharm degree, and obtained his Ph.D degree in medicinal chemistry and pharmacognosy, from the University of Illinois at Chicago. He conducted postdoctoral research on structure-activity relationships studies using molecular modeling at the University of Illinois working with Dr. John M. Pezzuto and at Pomona College working with Professor Corwin Hansch. Additionally, he had a sabbatical experience at NASA Ames Research Center in computer modeling. At the University of Arkansas for Medical Sciences he established and directs the molecular modeling facility. He has extensive research collaborations with many scientists locally, nationally and internationally." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Compadre has extensive research experience, on the development of bioactive compounds based on naturally occurring compounds, and on the use of molecular modeling in drug design and structure-activity studies" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--christopher-w-ho-11449.jpg" alt="Christopher W Ho" title="Christopher W Ho" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/christopher-w-ho-4643" title="Click here"><strong>Christopher W Ho</strong></a> <br>Assistant Professor, Department of Pharmacy Practice <br>Long Island University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Christopher Ho is an assistant professor at the Arnold and Marie Schwartz College of Pharmacy and Health Sciences in Brooklyn, NY. He earned his Bachelor of Science degree in Biochemistry from Stony Brook University and his Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences in Worcester, MA. He then moved on to complete a PGY1 pharmacy practice residency at the James J. Peters VA Medical Center in the Bronx, NY. He is board certified in ambulatory care and is currently practicing as a clinical pharmacy specialist in the ambulatory care areas of diabetes and primary care at the Brooklyn VA Medical Center, where he offers rotations for both pharmacy students and residents. At the college, he teaches courses in both the pharmacy and physician assistant programs in areas such as acute coronary syndromes, ischemic heart disease, colorectal cancer, and drugs of abuse. He is also currently the president-elect of the Royal Counties Society of Health-System Pharmacists and his research interests include the areas of diabetes and cardiology." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Diabetes and Cardiology." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--katerina-venderova-11545.jpg" alt="Katerina Venderova" title="Katerina Venderova" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/katerina-venderova-4644" title="Click here"><strong>Katerina Venderova</strong></a> <br>Assistant Professor, Department of Physiology and Pharmacology <br>University of the Pacific, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Venderova is an Assistant Professor at the University of the Pacific, with expertise in neuropharmacology and neurogenetics. Her research is centered on pathogenesis of neurodegenerative processes in an effort to find effective disease-modifying treatments. She received several international awards and fellowships in recognition of her work, such as the Melvin Yahr Fellowship, the Junior Faculty Award, and the Parkinson Society Canada basic research postdoctoral fellowship. She authored four textbook chapters, presented her findings at a number of invited talks, and serves as a reviewer for several highly respected journals and grant agencies. Prior to joining University of the Pacific’s Thomas J. Long School of Pharmacy, she was a postdoctoral fellow at the University of Ottawa, Faculty of Medicine, and at the Toronto Western Research Institute in Canada. She received a doctorate in pharmacy, followed by a PhD in Toxicology from the Charles University in Prague, Czech Republic." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Venderova’s core expertise is in genetics and molecular pathways involved in neurodegeneration, most notably in Parkinson’s disease and Alzheimer’s disease. The goal of her work is finding better pharmacological treatments of neurodegenerative disorders." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--amy-z-wang-11566.jpg" alt="Amy Z Wang" title="Amy Z Wang" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/amy-z-wang-4645" title="Click here"><strong>Amy Z Wang</strong></a> <br>Assistant Professor, Department of Pharmacy Practice <br>Long Island University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Amy Wang is an Assistant Professor of Pharmacy Practice at the Long Island University and a Clincial Pharmacy Specialist in Cardiology at the New York Methodist Hospital. She graduated from the University of Kentucky in 2006 with degrees of Doctor of Pharmacy and Master of Business Administration. She worked as a staff pharmacist after graduation at the Cleveland Clinic, in Cleveland, Ohio. Her Post-Graduate Year One Pharmacy Practice residency was completed at the St. John Hospital in Detroit, Michigan. Her Post-Graduate Year Two Critical Care residency was completed at the New York Methodist Hospital in Brooklyn, New York. Dr. Amy Wang took an Assistant Professor position at the Long Island University in 2009, and was BCPS certified in 2010. At New York Methodist Hospital, she attends daily clinical rounds with the Cardiology Team and precepts Pharmacy Residents and Pharmacy Students. Her research interests include anticoagulation, cardiology, and critical care." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="My research interests include comparing efficacy and safety of antiplatelets for acute coronary syndrome, comparing efficacy of magnesium and Class III antiarrhythmic therapy versus antiarrhythmics alone for atrial fibrillation, and efficacy of digoxin for pulmonary arterial hypertension." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--brian-w-dymock-11634.jpg" alt="Brian W Dymock" title="Brian W Dymock" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/brian-w-dymock-4646" title="Click here"><strong>Brian W Dymock</strong></a> <br>Associate Professor, Department of Pharmacy <br>National University of Singapore, Singapore </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Prof.Brian W Dymock has received his PhD in University of Glasglow, UK during the period of 1997. Currently, he is working as Associate Professor in University of Singapore. He has successfully completed his Administrative responsibilities as Department Manager, Discovery Chemistry, Evotec, UK, Visiting Associate Professor, NUS Department of Pharmacy, Singapore. He has authored 62 research articles. He is a full member of the Royal Society of Chemistry (MRSC), UK and member of the American Chemical Society, USA ." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="• Fragment screening using Surface Plasmon Resonance (SPR) and Weak Affinity Chromatography (WAC) • Hydrogen sulfide donor compounds as cardiovascular and anticancer agents • Designed Multiple Ligands (e.g. HDAC-HSP90, HDAC-JAK combination drugs) • Novel inhibitors of Histone Methyl Transferases (HMTs) • Novel inhibitors of kinesin enzymes • Targeting p53 modulators to cancer cells • Selective Inhibitors of mTOR kinase" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--hong-yu-li-11670.jpg" alt="Hong-yu Li" title="Hong-yu Li" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/hongyu-li-4647" title="Click here"><strong>Hong-yu Li</strong></a> <br>Associate Professor, Department of Pharmacology and Toxicology <br>The University of Arizona, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Hong-yu Li is currently an associate professor of Medicinal Chemistry in College of Pharmacy, the University of Arizona. He received his Ph.D. degree from the University of Tokyo, and did his postdoctoral trainings at Columbia University (with Professor Koji Nakanishi) and Harvard University (with Professor Yoshito Kishi). He previously worked at Eli Lilly where he focused on oncology drug discovery.His current research interests are in chemical biology and drug discovery, especially for oncology related targets and phenotypes.In his lab at the University of Arizona, a highly potent (picomolar activity in an oncogene-driven cancer cell line), selective, and orally bioavailable small molecule drug inhibitor was discovered, and is currently ready for preclinical development and further IND filing." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Li’s research interest is drug discovery and development of kinase inhibitors for rare and/or neglected cancer diseases in a High-Throughput manner. To discover active hits, a novel type of kinase fragment library will be generated in a High-Throughput manner. This kinase fragment library will be designed to overcome most of issues concerning kinase fragment libraries. Compounds identified from the library as an active will be further optimized for better activity and toxicity profiles. The optimization will be done through the library synthesis approach, rather than the industry standard approach of solving SAR (structure-activity relationship) problems one molecule at a time. The one-by-one approach may work well in the beginning of the sequence of the drug discovery value chain, but you may run the risk of encountering the initial problems when trying to solve the next problem. One-cycle library iteration will produce a wide range of SAR information including toxicity for the next library design and production. Three to five cycle iterations of libraries will generate advanced compounds with properties to produce the desired in vivo efficacy with acceptable toxicity profile. The library design approach aided by the computer modeling and calculation will focus on solving any unforeseen SAR problems for each cycle." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--zhe-sha-12452.jpg" alt="Zhe Sha" title="Zhe Sha" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/zhe-sha-4649" title="Click here"><strong>Zhe Sha</strong></a> <br>Department of Cell Biology, Harvard Medical School <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. ZheSha got his B.S. degree from the department of Biology at Fudan University. He then did his Ph.D. dissertation at Dr. Eric C. Chang’s laboratory at the Department of Molecular and Cellular Biology and the Lester & Sue Smith Breast Center at Baylor College of Medicine. His Ph.D. dissertation focused on identifying the mechanism by which Int6, a breast tumor suppressor gene, maintains protein homeostasis and genetic stability by promoting proper assembly and localization of the 26S proteasome. After graduation, Dr. Sha joined Professor Alfred L. Goldberg’s laboratory at the Department of Cell Biology at Harvard Medical School to conduct further research in the proteasome and cellular proteolysis area. His current research focuses on identifying cell killing mechanisms by proteasome inhibition, and cellular compensatory responses to promote survival." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Proteasome inhibition is toxic, especially to multiple myeloma cells, and the inhibitor, bortezomib/Velcade, has dramatically improved myeloma treatment. Diminished proteasome function also may contribute to neurodegenerative diseases. Consequently, understanding what consequences of proteasome inhibition causes death in various types of cells, and how different cells compensate for loss of protein degradation capacity in order to promote survival, will be very helpful to improve the Bortezomib therapy, and to pharmaceutically upregulate protein degradation capacity for the benefit of treating neurodegenerative diseases. To this end, I am pursuing two directions: (1) How do cells transcriptionally upregulate components of the ubiquitin-proteasome system and the autophagy-lysosomal system to increase protein degradation capacity; (2) How are proteasome composition (especially the abundance of substochiometric proteasome-binding proteins) and proteasome modifications are altered upon proteasome inhibition to modulate proteasome activity and amplify the inhibitory effect of Bortezomib." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--robert-chunhua-zhao-12527.jpg" alt="Robert Chunhua Zhao" title="Robert Chunhua Zhao" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/robert-chunhua-zhao-4650" title="Click here"><strong>Robert Chunhua Zhao</strong></a> <br>Director, Chinese Academy of Medical Sciences <br>China </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Robert Chunhua Zhao, M.D., Ph.D, is Cheung Kong Professor, Director of Center for Stem Cell and TE at CAMA& PUMC, the chief scientist of National 973 Basic Research Program of China and a Regional Editor of the Journal of Stem Cells and Development. His research is directed at studying the fundamental properties of stem cells and translating their unique biological properties into clinical application. In 2004 his group won the first official approval of “mesenchymal stem cell” from SFDA as to start clinical trials in China. Dr. Zhao has published 212 papers in international and domestic journals." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Studying the fundamental properties of stem cells and translating their unique biological properties into clinical application." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--beili-zhu-12547.jpg" alt="Beili Zhu" title="Beili Zhu" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/beili-zhu-4651" title="Click here"><strong>Beili Zhu</strong></a> <br>University of Texas Health Center, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="My project will be creating new methods and developing microfluidic devices to separate different types of cells from native cardiac and skin tissue for applications in tissue engineering and cell-based tissue repair." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--john-d-bullock-14192.jpg" alt="John D Bullock" title="John D Bullock" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/john-d-bullock-4652" title="Click here"><strong>John D Bullock</strong></a> <br>Research Professor of Epidemiology <br>Wright State University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Bullock is a graduate of Dartmouth College and Harvard Medical School. He completed an internship in internal medicine at Washington University in St. Louis before serving in the U.S. Navy. After residency training in ophthalmology at Yale University, he completed fellowships at the University of California, San Francisco, and the Mayo Clinic. He received a Master of Science in Microbiology and Immunology from Wright State University and a Master of Public Health degree from the Harvard School of Public Health. He completed additional training from the Armed Forces Institute of Pathology, the CDC in Atlanta, the London School of Hygiene and Tropical Medicine, and the Pasteur Institute in Paris. He held a clinical faculty position at Stanford University before coming to Wright State, where he served as professor and chair of the department of ophthalmology, professor of physiology and biophysics and associate professor of microbiology and immunology, and was named the Brage Golding Distinguished Professor of Research. Dr. Bullock is the author or coauthor of more than 235 scientific publications. He discovered three new causes of blindness and elucidated the etiology and/or description of six different retinopathies. His research influenced the market withdrawal of two general anesthetics, a warning label for a pharmaceutical agent whose inappropriate use resulted in blindness, and a Consumer Products Safety Commission-mandated warning label. He is a Fellow of the American Academy of Ophthalmology, the American Academy of Pediatrics, the Infectious Diseases Society of America, the American College of Epidemiology and the Royal Society of Medicine. He is a member of Alpha Omega Alpha Honor Medical Society, Delta Omega Honorary Society in Public Health, the American Ophthalmological Society, the American Osler Society, the Cornea Society (Member with Thesis) and the American Society for Microbiology, among others. Dr. Bullock received a Heed Fellowship from the Heed Ophthalmic Foundation; the Wendell Hughes, Merrill J. Reeh, and the Marvin H. Quickert Awards from the American Society of Ophthalmic Plastic and Reconstructive Surgery; and the Senior Honor Award from the American Academy of Ophthalmology. In 2011 he received the Outstanding Scientific Project Award from the Vision Care Section of the American Public Health Association. He has numerous other awards (including teaching awards), copyrights, trademarks and inventions. He has given more than 500 lectures throughout the world, a number of which were distinguished named lectureships, and he served as president and secretary/treasurer of two international medical societies. He has served as a consultant to the National Institutes of Health, the Hospital Albert Schweitzer in Haiti, the U.S. Veteran’s Administration, the U.S. Air Force, the American Medical Association, and the Harvard-Hsiao Resource-Based Relative Value Study." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Ophthalmology Anti-microbial agents" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs--sarsvatkumar-patel-14230.jpg" alt="Sarsvat Patel" title="Sarsvat Patel" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/sarsvat-patel-4653" title="Click here"><strong>Sarsvat Patel</strong></a> <br>Assistant Professor, Division of Pharmaceutical Sciences <br>Long Island University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Patel has received a Ph.D. in Pharmaceutics in 2010 from the National Institute of Pharmaceutical Education and Research (NIPER, India), an M. Pharm. in Pharmaceutical Technology (Formulations) from the NIPER, and a B.S in Pharmacy from the North Gujarat University, India. He joined the Division of Pharmaceutical Sciences in fall 2012 after working at the Department of Pharmaceutics, University of Minnesota, where he worked on many research projects related to preformulation, formulation development and pharmaceutical processing. He has published 16 research articles, filed 2 patent applications, worked on various industry-sponsored projects and received research grant. He is actively involved in research areas of pharmaceutics like – (i) Pre-formulation profiling (physico-chemical characterization, solubility, permeability), (ii) Pharmaceutical material characterization (amorphous, polymorphism, pseudo-polymorphism, salt, co-crystals), (iii) Manufacturing sciences (mechanical property, tableting, granulation, flow property) and (iv) Drug delivery to improve bioavailability. The research efforts are focused to “build-the–quality” within the drug products through pharmaceutical Quality by Design (QbD) concept. Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables. Dr. Patel guides students for major research programs like M.S. (Industrial Pharmacy) and Ph.D. He teaches various courses in both the graduate and entry-level programs." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="He is actively involved in research areas of pharmaceutics like – (i) Pre-formulation profiling (physico-chemical characterization, solubility, permeability), (ii) Pharmaceutical material characterization (amorphous, polymorphism, pseudo-polymorphism, salt, co-crystals), (iii) Manufacturing sciences (mechanical property, tableting, granulation, flow property) and (iv) Drug delivery to improve bioavailability. The research efforts are focused to “build-the–quality” within the drug products through pharmaceutical Quality by Design (QbD) concept. Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-srinivasan-shanmugam-16700.jpg" alt="Srinivasan Shanmugam" title="Srinivasan Shanmugam" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/srinivasan-shanmugam-4654" title="Click here"><strong>Srinivasan Shanmugam</strong></a> <br>Project Leader, Formulation R&D, Hanmi Pharm. Co. Ltd. <br>South Korea </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Srinivasan Shanmugam received his Ph.D. in Pharmaceutical Science from the College of Pharmacy, Yeungnam University in 2010. During his doctoral studies, his research was on liposomes, niosomes, and chemical enhancers for topical delivery and self-emulsifying drug delivery systems (SNEDDS) for oral delivery. He received his MS in Pharmaceutical Sciences in the same university in the year of 2007, and his research focus during this period was on mixed micellar nanoparticles for parenteral and liposomes for topical delivery. His undergraduate major was Pharmacy (Bachelor of Phramacy) and received his degree in the year of 1999 with research focus on “Endothelin Receptors.” Right after undergraduate degree, he gained hands on experience in manufacturing of solid/liquid dosage formulations by working in pharmaceutical companies for about five years. Currently, Dr. Shanmugam is a Project Leader (Principal Scientist) in Formulation R&D Division of Hanmi Pharm. Co. Ltd., South Korea. His research focuses on design and development of conventional, NDDS/alternate/advanced, and modified drug delivery systems, and platform technologies. He has successfully designed, developed, and implemented various platform technologies to enhance oral bioavailability of highly hydrophilic drugs, poorly bioavailable highly lipophilic drugs, etc. Dr. Shanmugam has published numerous research articles in prestigious pharmaceutical sciences journals and presented more than 20 of his work in various symposiums/conferences globally. He is also a reviewer and editorial member of various journals." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="His research interests include but not limited to the following; Drug Delivery Systems: Conventional systems (tablets, capsules, emulsions, and suspensions) Novel delivery systems (lipid formulations, micro/nano emulsions/self-emulsifying, micelles, liposomes/niosomes/cubosomes, multiparticulate, and pulsatile/targeted delivery ssytems). Drug Delivery Techniques: Dissolution/solubility/stability enhancement Bioavailability enhancement (oral/lymphatic/transdermal) Perrmeability enhancement (oral/topical/transdermal) Drug Delivery Technologies: Modified release (sustained/delayed/controlled/pulsatile/targeted) Spray/freeze drying, and fluid bed drying" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-jayanthi-repalli-17227.jpg" alt="Jayanthi Repalli" title="Jayanthi Repalli" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/jayanthi-repalli-4655" title="Click here"><strong>Jayanthi Repalli</strong></a> <br>NYU Langone Medical Center <br>New York, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Extensive experience in the areas of drug discovery and design for cancer and neurodegenerative diseases" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-vikas-bhat,-ph.d.-17229.jpg" alt="Vikas Bhat" title="Vikas Bhat" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/vikas-bhat-4656" title="Click here"><strong>Vikas Bhat</strong></a> <br>Department of Medicine <br>University of California, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Leading a collaborative interdisciplinary project to develop and test protein based drug molecules for the treatment of various bleeding complications associated with hemophilia patients or patients using various anticoagulants. Cloning and purification of recombinant protein using mammalian cells. Develop and optimize in-vitro assays for physicochemical characterization of potential protein drug candidates. Conduct both enzyme-based and ligand binding in-vitro assays and provide support for drug discovery programs throughout the lead optimization process. Develop novel drug delivery systems in different mice models and analysis of results thereof. Validate the successful candidates in different cell and mouse models. Conduct in vivo pharmacokinetic and metabolism studies of potential drug candidates in animals, integrate results with in vitro and biological findings and report data." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/-vural-fidan-17590.jpg" alt="Vural Fidan" title="Vural Fidan" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/vural-fidan-4657" title="Click here"><strong>Vural Fidan</strong></a> <br>Department of Medicine <br>Hacettepe University, Turkey </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr Vural Fidan has recieved his MD and PhD in Hacettepe University. He is deputy director of ENT department. He is an Otorhinolaryngologist at Yunus Emre Goverment Hospital. He worked as a visiting scientist at Yale University ENT and Allegry departments. He has more than 20 SCI indexed articles. Research interests are pulmonary hypertension, allergy, otology, rhinology and sleep medicine." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Research interests are pulmonary hypertension, allergy, otology, rhinology and sleep medicine" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-raktim-kumar-ghosh-17593.JPG" alt="Raktim Kumar Ghosh" title="Raktim Kumar Ghosh" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/raktim-kumar-ghosh-4658" title="Click here"><strong>Raktim Kumar Ghosh</strong></a> <br>Department of Internal Medicine <br>Case Western Reserve University, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Ghosh is currently serving as chief resident in the Department of Internal Medicine, St. Vincent Charity Medical Center, An Affiliate of Case Western Reserve University, Cleveland, OH, USA. He finished a residency in Clinical Pharmacology from a premier medical institute in India, followed a clinical research fellowship from Outcomes Research, Cleveland Clinic, OH. Dr. Ghosh has published more than 20 original articles, review and case reports in high index journals. He has currently serving as reviewer and editorial member of various journals. He is current member of ASCO, ACP and SGIM societies and presented in various internal medicine meetings in USA. His research interests include newer drug development in oncology, diabetes and thrombosis." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="His research interests include newer drug development in oncology, diabetes and thrombosis." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-varun-khurana-19779.jpg" alt="Varun khurana" title="Varun khurana" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/varun-khurana-4659" title="Click here"><strong>Varun khurana</strong></a> <br>Formulation Scientist, INSYS Therapeutics.INC <br>Chandler, AZ, USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Varun Khurana obtained his Bachelors in Pharmacy from Guru Gobind Singh Indraprastha University, Delhi,, India. Dr. Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO, USA. Currently, he is working as Formulations Scientist at Insys Therapeutics, Inc., USA, a specialty pharmaceutical company that develops and commercializes innovative supportive care products. Dr. Khurana’s research experience encompasses both industry and academia. Dr. Khurana worked on National Institutes of Health (NIH) funded research projects. Dr. Khurana’s research was focused on understanding the role of drug transporters (influx as well as efflux) in disposition of various anti-cancer drugs. He not only studied the alteration of drug pharmacokinetics via drug transporters in liver but also how the modulation affects brain as well plasma pharmacokinetics of anti-cancer drugs. Furthermore, his research work was focused on ocular drug delivery through nanoparticles. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences. Dr. Khurana’s current research at Insys Therapeutics is focused on development of oral solutions and sublingual sprays for new product development." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Novel Drug Delivery Systems, Solubility and Bioavailability Enhancement, Targeted Drug Delivery, Cancer Therapy, Targeted Delivery, Gene Therapy, Nanotechnology, Novel Drug Delivery Systems, Formulation Development (Oral solids, Liquid and Parenterals), Controlled or Modified Release." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-alex-chang-zou-19982.jpg" alt="Alex Chang ZOU" title="Alex Chang ZOU" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/alex-chang-zou-4660" title="Click here"><strong>Alex Chang ZOU</strong></a> <br>School of Biomedical Sciences <br>The Chinese University of Hong Kong, China </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Alex Chang ZOU, is a qualified physician and treated both emergency and in-hospital patients with surgical disorders as in Dong Rui Hospital, Nanjing, China. He is presently working as Deputy Director in Clinical Research Centre. His previous research work includes: 1. Selection and validation of esophageal cancer cell targeting phage-displayed peptides. 2. Dose-effect curve study and new applications development of human recombinant endostatin. 3. Preclinical study of an anti-VEGF monoclonal antibody drug. Functional study of estrogen-related receptor alpha in prostate cancer. 4. Estrogen-related receptor alpha in Castration-Resistance Prostate Cancer. He also provided an original idea and prepared preliminary data for the grant applying and found that ERRïÂ脗聛¡ overexpression in prostate cancer contribute to its Bicalutamide-resistance and androgen independent growth both in vitro and in vivo." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Molecular cloning techniques; protein-protein interaction analysis: Co-IP, FRET, phage-displayed peptide library screening and identification (in vivo and in vitro); tumor angiogenesis analysis (in vitro and in vivo); histology techniques (slices and IHC); tissue culturing; construction and identification of sub-cell line by both transfection and infection; polyclonal antibody production in rabbit and purification, animal handling: tumor xenograft model constructing in mice subcutaneously and orthotopic, drug administration in mice by garage, i.p. and i.v. by tail vein." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-rajesh-rajan-wakaskar-23512.jpg" alt="Rajesh Rajan Wakaskar" title="Rajesh Rajan Wakaskar" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/rajesh-rajan-wakaskar-4661" title="Click here"><strong>Rajesh Rajan Wakaskar</strong></a> <br>Formulation Scientist, Insys Therapeutics <br>India </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Rajesh R Wakaskar has received his Ph.D. in Pharmaceutical Sciences from the University of Nebraska Medical Center in 2015. Currently, he is working as a Formulation Scientist at Insys Therapeutics. His current profile encompasses providing support in Pre-formulation and Formulation Development, Clinical supplies manufacture, API and Drug Product Stability and writing CMC sections of the IND and NDA that are submitted to the FDA for review and approval of pharmaceutical products. His graduate project involved the development of shell cross-linked polymeric micelles (nanocarriers) for the delivery of poorly water soluble anti-cancer agents such as Combretastatin A4 (CA4) to improve the existing solubility, efficacy, bioavailability of this drug, and subsequently, overall therapy of breast cancer. Based on his research, he has been awarded several honors in various podia and poster presentations at various conferences and is an author of high impact research articles in reputed journals. Currently, he’s serving as an expert reviewer for various Journals such as Journal of Drug Delivery, Science and Technology, Clinical Pharmacology & Biopharmaceutics Journal, Cardiovascular Pharmacology, Advances in Pharmacoepidemiology & Drug Safety, Journal of Applied Pharmacy, Pharmaceutical Sciences, Journal of Molecular Biomarkers and Diagnosis (to name a few)." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Developing and improving upon the existing concepts of drug delivery. Providing specific insights into the development of nanotechnology, both as a therapeutic and diagnostic tool. Aiding the successful transition of bench-scale science to clinical development of therapeutic products" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journalofdevelopingdrugs-niket-patel-23765.jpg" alt="Niket Kumar Patel" title="Niket Kumar Patel" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/niket-kumar-patel-4662" title="Click here"><strong>Niket Kumar Patel</strong></a> <br>Sr. Staff Formulator, Charles River Laboratories <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr Niket Kumar Patel obtained his Ph.D. from St. John’s University, USA in 2013. Dr. Patel’s research is focused on transdermal iontophoretic delivery of Tacrine Hydrochloride for treatment of Alzheimer’s disease. During his PhD, he developed the formulation loaded patches for iontophoretic delivery of tacrine hydrochloride focusing on in vitro-in vivo correlation study. Furthermore, he have also worked in the research area of ethosomes, transferosomes, solid lipid nanoparticles, solid dispersion, microemulsion creams and hydrogels. He have published 8 publications in prestigious international journals and 2 book chapters. Dr. Patel have also served as a distinguished editorial board member/ reviewer in more than 10 international journals and was an invited judge in AAPS, and NJPHAST conferences. He is currently working at QS Pharma, USA as senior formulation scientist where he works on the formulation development of Phase- I, II and III clinical trial materials." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Topical and transdermal delivery, Iontophoretic drug delivery, Formulation of liposomes, Ethosomes, Microemulsion, and Solid lipid nanoparticles Oral delivery: dissolution enhancement techniques including particle size reduction, solid dispersion, SMEDDS and drug nanoparticles, controlled release and modified release oral delivery such as tablets, microspheres. Disintergation, Dissolution, Design of experiments, Quality by Design and PK studies, IVIVC" data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs-dev-prasad-25346.jpg" alt="Dev Prasad" title="Dev Prasad" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/dev-prasad-4663" title="Click here"><strong>Dev Prasad</strong></a> <br>Senior Scientist-I in Formulation, Development Klus Pharma Inc., Monmouth Junction, New Jersey <br>USA </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dev Prasad, M.S., Ph.D., Education Year Institute Degree Earned GPA Jan 2010 -May 2014 School of Pharmacy Massachusetts College of Pharmacy and Health Sciences, (MCPHS) University, Boston, MA, USA Doctor of Philosophy (Ph.D.) in Pharmaceutics and Drug Design 3.98/4 Sept. 2007 -Dec 2009 School of Pharmacy Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Boston, MA, USA M.S., Pharmaceutics & Drug Design 3.98/4 Sept. 2001 -July 2005 U.P. Technical University, Lucknow, India Bachelor of Pharmacy 3.5/4 Professional Employment June 2017 -present Senior Scientist-I, Formulation Development Klus Pharma Inc., Monmouth Junction, New Jersey AugMay 2014 -June 2017 Senior Scientist, Formulation & Product Development Fresenius Kabi USA, Skokie, Illinois May 2013 -Aug 2014 Ph.D. Co-op/Scientist I, Discovery Pharmaceutics Cubist Pharmaceuticals, Lexington, MA May 2011 - Aug 2011 Research Intern, Vertex Pharmaceuticals, Cambridge MA May 2010 - Aug 2010 Research Intern, Vertex Pharmaceuticals, Cambridge MA May 2008 - Aug 2008 Research Intern, Vertex Pharmaceuticals, Cambridge MA Oct 2004 - July 2005 Medical Detailing Officer Nestle, India Professional Experience Sept. 2007 -May 2013 Instructor/Teaching Assistant Massachusetts College of Pharmacy and Health Sciences, Boston, MA May 2011 -Aug 2011 Research Intern Vertex Pharmaceuticals, Cambridge, MA May 2010 -Aug 2010 Research Intern Vertex Pharmaceuticals, Cambridge, MA May 2008 -Aug 2008 Research Intern Vertex Pharmaceuticals, Cambridge, MA Dev Prasad 2 Leadership and Professional Activities Reviewing and Judging of Scientific Publications Manuscripts Peer Review Year Name of the Journal Role Manuscripts reviewed 2017 - present Current Drug Safety, Bentham Science Reviewer 1 2017 - present Frontiers Health Production, Frontier Reviewer 3 2016 - present Medical Science Monitor Reviewer 8 2016 - present Drug Delivery and Translational Research, Springer Reviewer 2 2016 - present The AAPS Journal Reviewer 1 2016 - present ADMET & DMPK/IAPC, IAPC Publishing Reviewer 1 2015 - present SOJ Pharmacy & Pharmaceutical Sciences, Symbiosis online publishing Reviewer 1 2015 - present Journal of Pharmaceutical Investigation, Springer Reviewer 18 2015 - present Talanta, Elsevier Reviewer 1 2015 - present AAPS PharmSciTech Reviewer 1 2013-Present AAPS Annual Meeting Abstract Reviewer 50+ Book Proposal Review Year Name of the Publisher Role 2017 Nanotechnology: therapeutic, nutraceutical and cosmetic advances, CRC press Reviewer 2017 Design of Experiments in Pharmaceutical Product Development: Fundamentals and Applications, CRC Press/ Taylor and Francis Group Reviewer Year Organizations Role 2012- present Sigma Xi, The Scientific Research Society Member 2012- present Rho Chi, The Academic Honor Society in Pharmacy Member 2011 American Association of Pharmaceutical Northeast- Regional discussion group (AAPS-NERGD) Planning committee member 2010 American Association of Pharmaceutical Scientists- Graduate Research Association for Students (AAPS-GRASP) Planning committee member 2011-2012 Graduate Student Association, MCPHS, MA President 2008-2010 Graduate Student Association, MCPHS, MA Vice-President 2007-08 American Association of Pharmaceutical Scientists-MCPHS chapter Vice Chair Dev Prasad 3 Others Year Name of the Awards Role 2017 CPhl Pharma Awards, Recognizing excellence in pharma Jury member 2016 CPhl Pharma Awards, Recognizing excellence in pharma Jury member Awards & Recognitions 2014 EUDRAGIT® Award 2014 for best peer reviewed research article by Evonik Health Care 2012 American Association of Pharmaceutical Scientists travel-ship award recipient- Formulation Design and Development (AAPS-FDD) section Research Interest: Senior Scientist-I, Formulation and Product Development Klus Pharma, Monmouth Junction, NJ • Developed generic (ANDA) injectable formulations in a cGMP environment. • Designed and developed sterile injectable solution, lyophilized product, and ready-to-use solution as a lead scientist. Executed packaging insert support studies (Photo-stability, Thermal cycling, LVP admixture compatibility study). • Process development of parenteral product for pilot and commercial manufacturing. • Responsible for preparing CMC regulatory filling submissions documents (3.2.P.2, P.5.6 etc.). • Works in interdisciplinary team with scientists from Analytical, Quality Assurance, Project Management, Regulatory Affairs, Manufacturing and Tech. Transfer teams to ensure timely completion of development and manufacturing activities Senior Scientist, Formulation & Product Development Fresenius Kabi USA, Skokie, IL • Developed novel 505 (b) (2) and generic (ANDA) injectable formulations in a cGMP environment. • Initiated feasibility of anti-cancer and anti-fungal compounds for value-added NDA formulation. Evaluated various drug delivery systems for parenteral formulation. • Developed and optimized lyophilization cycles based on Differential Scanning Calorimetry (DSC) and Freeze Dry Microscopy (FDM). Solved vial breakage and lyo cake collapse issue. • Responsible for process development, successful manufacturing of in-house lab scale and pilot scale batches and technology transfer of parenteral product to manufacturing plants. • Developed stability testing protocols (STPs) and executed stability studies for lab batches, pilot scale batches and exhibit batches. • Responsible for preparing CMC regulatory filling submissions documents (3.2.P.2, P.5.6 etc.). • Works in interdisciplinary team with scientists from Analytical, Quality Assurance, Project Management, Regulatory Affairs, Manufacturing and Tech. Transfer teams to ensure timely completion of development and manufacturing activities. Graduate (M.S. and Ph.D. Research) - Formulation of poorly water soluble drugs -Novel Drug Delivery • Explored the role of drug polymer interaction in improving amorphous state stabilization and dissolution rate in ternary solid dispersions formulations. • Conducted solid-state characterization and in-vitro dissolution studies of solid dispersion. • Evaluated different polymers for precipitation inhibition of drugs in solution and Dev Prasad 4 Systems development of their amorphous solid dispersions. • Developed Self Emulsifying Drug Delivery System (SEDDS) for poorly soluble drug. • Studied the effect of excipients on precipitation inhibition of indomethacin from upon in-vitro dilution from SEDDS. • Evaluated the stability of Vitamin B complex in the space retrieved tablets - NASA funded. Publications: Book Chapters (Total- 4; Citations- 13) 1. D. Prasad, A. Jain, S. Garad, “Oral delivery of poorly soluble drugs”, in Poorly Soluble Drugs: Dissolution and Drug Release, CRC Pan Stanford, DOI: 10.1201/9781315364537-6, Jan 2017, 125-186 Role: First Author 2. D. Prasad and H. Chauhan. "Excipients Utilized for Ophthalmic Drug Delivery Systems." In Nano-Biomaterials for Ophthalmic Drug Delivery, pp. 555-582. Springer International Publishing, 2016. Role: First Author 3. H. Chauhan, J. Bernick, D. Prasad, and V. Masand, “ANN on Target Validation as Robust Tool in Drug Discovery and Development”, Artificial Neural Network for Drug Design, Delivery and Disposition, Edited by Puri, Pathak, Sutariya, Tipparaju, Moreno, Release Date 22 Oct 2015, Academic Press, Print Book ISBN :9780128015599, eBook ISBN :9780128017449. Role: Co-Author 4. D. Prasad and H. Chauhan. "Nanotoxicity of Polymeric and Solid Lipid Nanoparticles” In Sutariya, Vijaykumar B., and Yashwant Pathak, eds. Biointeractions of nanomaterials. CRC Press, 2014. Role: First Author Citation: 13 Peer-reviewed articles (Total- 10; Citations- 111) 1. D. Prasad, H. Chauhan, E. Atef, “Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solutions”. Molecular Pharmaceutics, 2016 (13), 756-765. Impact factor: 4.384 Role: First Author Citation: 9 2. D. Prasad, A. Kuldipkumar, C. Gu. “Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs”. Pharmaceutical development and technology, 2016, 21(4), 511-517. Impact factor: 1.86 Role: First Author Citation: 1 3. D. Prasad, H. Chauhan, E. Atef, “Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects”. J. of Pharma Sciences, 2014, 103 (11), 3511-3523 Impact factor: 3.35 Role: First Author Citation: 34 4. F. Meng, A. Trivino, D. Prasad, H. Chauhan, “Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions”. European J. of Pharm. Sciences, 2015, 71, 12-24 Impact factor: 3.350 Role: Co-Author Citation: 35 Dev Prasad 5 5. D. Prasad, H. Chauhan, “Key targeting approaches for pharmaceutical drug delivery”. American Pharmaceutical Review, Oct 2013 Impact factor: 0.35 Role: First Author Citation: none 6. D. Prasad, H. Chauhan, E. Atef, “Studying the effect of lipid chain length on the precipitation of a poorly water-soluble drug from Self Emulsifying Drug Delivery System (SEDDS) on dispersion into aqueous medium”, J. of Pharmacy and Pharmacology, 2013, 65 (8), 1134-1144. Impact factor: 2.264 Role: First Author Citation: 15 7. M. Chuong, N. Aggarwal, D. Prasad, S. Mashiana, A. Taheri, W. Albenayan “Particle shape descriptors and angle of repose of a bimodal distribution sample”, International J. of Pharmacy & Technology, 2012, 4 (2), 4484- 4492. Impact factor: None Role: Co-Author Citation: none 8. E. Atef, H. Chauhan, D. Prasad, D. Kumari, C. Pidgeon “Quantifying solid-state mixtures of crystalline indomethacin by Raman spectroscopy comparison with thermal analysis”, ISRN Chromatography, 2012,1-6. Impact factor: None Role: Co-Author Citation: 15 9. M. Chuong, D. Prasad, B. LeDuc, B. Du and L. Putcha, “Stability of vitamin B complex in multivitamin and multimineral supplement tablets after space flight”, J. of Pharmaceutical and Biomedical Analysis, 2011, 55, 1197-1200 Impact factor: 3.25 Role: Co-Author Citation: 2 10. D. Prasad “Review: Pharmaceutical Nanocarriers”, Pharma Review, 2010 Impact factor: Role: None Citation: none Presentations Podium Presentations 1. D. Prasad, “Effect of drug polymer interaction on precipitation inhibition and amorphous stabilization of ternary systems”, AAPS-North-East regional annual meeting, April 2013. 2. D. Prasad, “The effect of low concentration of molecularly interacting polymers on indomethacin precipitation and its amorphous stabilization”. MCPHS, Annual GRASP conference 2011. 3. D. Prasad, “Investigating the effect of various oils on precipitation inhibition of indomethacin from self-emulsifying drug delivery system (SEDDS) upon in-vitro dilution”. Campbell University, Annual GRASP conference 2010. Poster Presentations: 1. D. Prasad, H. Chauhan, E. Atef, “Stabilization of ternary solid dispersions at high drug load using molecularly interacting polymers”, AAPS annual meeting 2012. 2. D. Prasad, M. S. Nagarsenker, H. Chauhan, “Thermal characterization of solid lipid nanoparticles containing Gelucire 44/14 and Gelucire 50/13”, AAPS annual meeting 2012. Dev Prasad 6 3. D. Prasad, H. Chauhan, E. Atef, “Utilizing 1H NMR in understanding the effect of polymers, individual and in combination, on precipitation inhibition of Indomethacin and its solubility enhancement from solid dispersions”, ACS annual meeting 2012. 4. D. Prasad, J. Beniek, H. Chauhan, “In−silico predictions for the development of poorly soluble anticancer drugs as amorphous systems”, ACS annual meeting 2012. 5. D. Prasad, E. Atef,, “The effect of low concentration of molecularly interacting polymers on indomethacin precipitation and its amorphous stabilization”, AAPS annual meeting 2011. 6. D. Prasad, B. Song, “Estimation of drug polymer miscibility and solubility at room temperature”, Vertex fun and fear intern poster presentation, Vertex Pharma. Inc. 2011. 7. D. Prasad, A. Kuldipkumar, C. Gu, “Development of biorelevent simulated intestinal media mimicking the intestinal environment to predict the solubility profiles of poorly soluble drugs”, Vertex fun and fear intern poster presentation, Vertex Pharma. Inc. 2010. 8. E. Atef, D. Prasad, H. Chauhan, “Quantifying solid mixture of alpha and beta indomethacin using raman and differential scanning calorimetry”, AAPS annual meeting 2010. 9. D. Prasad, E. Atef, “Investigating the mechanism of indomethacin precipitation inhibition from Self Emulsifying Drug Delivery System (SEDDS) upon in-vitro dilution: Effect of various oils”, AAPS annual meeting 2010. 10. M. Chuong, D. Prasad, B. LeDuc, B. Du, L. Putcha, “Pharmaceutical stability of vitamin B complex in the outer space bio-environments retrieved multi-vitamin and multi-mineral supplements”, AAPS annual meeting 2009. 11. H. Chauhan, D. Prasad, E. Atef, “Effect of PVP K90 on indomethacin, dipyridamole and progesterone crystallization in solution at different supersaturations”, AAPS annual meeting 2009. 12. D. Prasad, S. Roday, “Development of amorphous solid dispersions systems using amino acids”, AAPS-NERGD regional annual meeting 2009. 13. D. Prasad, H. Chauhan, E. Atef, “Preparation and stabilization of amorphous solid dispersions using Eudragits”, AAPS-MCPHS poster day 2008." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Research Interest The research is an integral part of the academician. During my graduate pursue and industrial exposure, I have developed a keen interest in the preformulation and formulation aspect of the drug development. Presently, my research interests involve working on following areas but I am open to learn and collaborate on new ideas and concepts in the field of pharmaceutical sciences. 1. To improve the solubility of different poorly soluble drugs (having different physic-chemical properties) by using approaches such as Solid dispersion, Self emulsifying drug delivery system (SEDDS), Nano-crystal systems and Supersaturated system. The idea is to develop a robust solubilizing technique that can effectively be used during prefomulation and formulation studies for New Chemical Entity (NCE). 2. To explore and characterize Ternary Solid dispersion as an approach to increase solubility and stability. The focus is to explore the combination of potential, used available, safe, FDA approved, well studied polymers. 3. To focus on understanding the precipitation mechanism of poorly soluble drugs in absence and presence of polymers (primarily by drug polymer interaction). The idea is to establish a correlation of drug polymer interaction in solution and its effect on the stabilization of amorphous solid state along with In-Silico prediction of drug polymer interaction by using softwares like Gaussian and Jaguar. Overall, the goal of the study is to help in rationally screening the polymers for improving drug solubility and stability. 4. In the future, I would like to study the effect of important factors like physicochemical properties, crystal form, morphology, seeding, and level of supersaturation etc. of various poorly soluble drugs in presence and absence of different excipients. The idea is to understand the crystallization/precipitation process in detail and apply in above mentioned solubilization techniques. It can help in understanding drug delivery and dosage form design aspects as a lot of excipients are added in formulation during various stages of drug development. 5. Another area of research I wish to pursue is the liposome based delivery systems. These nanocarriers have been well studied across multiple scientific disciplines (medicine, immunology, diagnostics, cosmetics etc.) over the last several decades and are considered one of the most advanced drug delivery systems in terms of development as reflected in the commercialization of liposome delivery systems in the area of oncology. Along with anti-cancer agents, I want to extend the use of liposome in other therapeutic areas such as anti-infectives and anti-inflammatory. Also, pharmaceutical science is one of the interdisciplinary fields where thoughtful collaboration among researchers in academics as well as industry is very important. Through these collaborations a rapid advancement can be made to solve a problem, so I would love to collaborate and make progress in my chosen field." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> <li class="list-group-item px-0"> <div class="row"> <div class="col col-sm-2"> <img src="https://www.longdom.org/admin/editor-photos/journal-of-developing-drugs-dr.-sisir-nandi--26739.jpg" alt="Dr. Sisir Nandi" title="Dr. Sisir Nandi" class="img-thumbnail img-fluid" width="100" height="100"> </div> <div class="col col-sm-10"> <p class="card-text font-size-3"> <a href="https://www.longdom.org/editor/dr-sisir-nandi-4664" title="Click here"><strong>Dr. Sisir Nandi</strong></a> <br>Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research <br>India </p> <nav class="nav a-mx-2"> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Dr. Sisir Nandi completed Ph.D. from Indian Institute of Chemical Biology (CSIR), Kolkata as a CSIR -GATE fellow and had been awarded Ph. D. in Pharmacy degree (2011) by the Jadavpur University, India. He did his Post-Doctoral research based on the prediction of new promising cycloaddition reactions: quantum chemical calculations and reactions modeling at transition state levels using different basis sets and theory under the European Union Marie Curie fellowship in Laboratory of Chemometrics, National Institute of Chemistry, Ljubljana, Slovenia, Europe. His specialization is Pharmaceutical Chemistry and research is based on the area of Pharmacoinformatics related rational drug design which includes QSAR & drug design, biological activity prediction of lead compounds, ligand-receptor interactions, virtual screening, combinatorial library design and lead-hopping. He published more than 50 original research articles and reviews in reputed international journals having high impact factor. He presented his research work in many international conferences around the world. He is the reviewers of many research articles of Medicinal Chemistry Research, Journal of Bioanalysis and Biomedicine, ASSAY and Drug Development Technologies, Combinatorial Chemistry & High Throughput Screening, Arabian Journal of Chemistry, Letters in Drug Design and Discovery, Current Medicinal Chemistry. He is Editorial advisory board of Journal of Bioanalysis and Biomedicine, Advanced Techniques in Clinical Microbiology, Journal of Computational Methods in Molecular Design; Indo American Journal of Pharmacy, EC Microbiology, Guest Editor of Current Signal Transduction Therapy and Associate Editor of Open Access Journal of Medicinal Chemistry; International Journal of Pharma Research and Health Sciences; Bioequivalence & Bioavailability International Journal (BEBA). He is having more than 12 years of research experience." data-original-title=""> Biography </a> <a tabindex="0" class="nav-link btn btn-sm btn-outline-info" role="button" data-html="true" data-container="body" data-toggle="popover" title="" data-placement="auto" data-content="Pharmacoinformatics based QSAR & Drug Design, molecular docking, scoring function analysis, computational tools for drug discovery, design, lead optimization, virtual screening, combinatorial library design, lead-hopping, quantum chemical calculations and reactions modelling at transition state levels using different basis sets and theory." data-original-title=""> Research Interest </a> </nav> </div> </div> </li> </ul> </main> </div> </div> </section> <footer class="bg-blue-grey-900 py-3"> <div class="container"> <div class="row"> <div class="col-12 col-sm-4"> <h4 class="white font-size-4 fweight-400 border-bottom-1 pb-2">Content Links</h4> <ul class="list-unstyled footer-links font-size-3"> <li><a class="" href="https://www.longdom.org/online-tools.html" title="Click here">Tools</a> </li> <li><a class="" href="https://www.longdom.org/feedback.html" title="Click here">Feedback</a></li> <li><a class="" href="https://www.longdom.org/careers.html" title="Click here">Careers</a></li> <li><a class="" href="https://www.longdom.org/privacy-policy.html" title="Click here">Privacy Policy</a></li> <li><a class="" href="https://www.longdom.org/terms-conditions.html" title="Click here">Terms & Conditions</a></li> <li><a class="" href="https://www.longdom.org/authors-reviewers-editors.html" title="Click here">Authors, Reviewers & Editors</a></li> </ul> </div> <div class="col-12 col-sm-4"> <h4 class="white font-size-4 fweight-400 border-bottom-1 pb-2">Contact Longdom</h4> <p>Longdom Group SA<br> Avenue Roger Vandendriessche,<br> 18, 1150 Brussels, Belgium<br> Phone: +442038085340 <br><strong>Email:</strong> <a href="mailto:info@longdom.org" class="white" title="Click here">info@longdom.org</a></p> </div> <div class="col-12 col-sm-4"> <h4 class="white font-size-4 fweight-400 border-bottom-1 pb-2">Connect</h4> <nav class="nav nav-pills social-icons-footer flex-column a-pl-0"> <a href="https://www.facebook.com/longdompublisher" title="Click here" target="_blank" class="nav-link bg-facebook-hover"><i class="fab fa-facebook-f bg-facebook"></i> Facebook</a> <a href="https://www.linkedin.com/company/longdom-publishing-sl/" title="Click here" target="_blank" class="nav-link bg-linkedin-hover"><i class="fab fa-linkedin-in bg-linkedin"></i> Linkedin</a> <a href="https://twitter.com/LongdomP" title="Click here" target="_blank" class="nav-link bg-twitter-hover"><i class="fab fa-twitter bg-twitter"></i> Twitter</a> <a href="https://www.instagram.com/longdom_publisher/" title="Click here" target="_blank" class="nav-link bg-instagram-hover"><i class="fab fa-instagram bg-instagram"></i> Instagram</a> </nav> </div> </div> <div class="row text-center"> <div class="col"> <p>Copyright © 2024 <a href="https://www.longdom.org/" title="Click here" class="white">Longdom Publishing</a>.</p> </div> </div> </div> </footer>  <a href="#0" class="cd-top js-cd-top">Top</a>   <script defer src="https://code.jquery.com/jquery-3.3.1.min.js"></script> <script defer src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js"></script> <script defer src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js"></script>  <script> jQuery(function($) { $(window).scroll(function fix_element() { $('#target').css( $(window).scrollTop() > 100 ? { 'position': 'fixed', 'top': '440px' } : { 'position': 'absolute', 'top': '440px' } ); return fix_element; }()); }); </script>   <script defer src="https://unpkg.com/feather-icons"></script> <script> feather.replace() </script>  <script defer src="/assets/js/scroll-to-top.js"></script>  <script defer type="text/javascript" src="/assets/js/coolautosuggest.js"></script> <script language="javascript" type="text/javascript"> $("#keyword").coolautosuggest({ url: "https://www.longdom.org/author-names.php?chars=", minChars: 3, }); </script> <script defer src="/assets/js/jquery.mCustomScrollbar.concat.min.js"></script> <script> // Scrollbar var Scrollbar = function() { "use strict"; // Handle Scrollbar Linear var handleScrollbarLinear = function() { $(".scrollbar").mCustomScrollbar({ theme: "minimal-dark" }); } return { init: function() { handleScrollbarLinear(); // initial setup for scrollbar linear } } }(); $(document).ready(function() { Scrollbar.init(); }); /*========================== Stikcy Navbar ============================*/ window.onscroll = function() { myFunction() }; var navbar = document.getElementById("sticky-navbar"); var sticky = navbar.offsetTop; function myFunction() { if (window.pageYOffset >= sticky) { navbar.classList.add("sticky") } else { navbar.classList.remove("sticky"); } } /*========================== Bootstrap Popover ============================*/ $(function () { $('[data-toggle="popover"]').popover() }) </script>  <script defer src="/assets/js/jquery.malihu.PageScroll2id.min.js"></script> <script> (function($){ $(window).on("load",function(){ $("a[rel='m_PageScroll2id']").mPageScroll2id(); }); })(jQuery); </script>  <script defer type="text/javascript" src="/assets/js/jquery.matchHeight-min.js"></script> <script> $(function() { $('.match-height').matchHeight({ byRow: true, property: 'height', target: null, }); }); </script> <script defer type="text/javascript" src="/assets/js/grids.min.js"></script> <script type="text/javascript"> // Equal Height var EqualHeight = function() { "use strict"; // Handle Equal Height var handleEqualHeight = function() { $(function($) { $('.equal-height').responsiveEqualHeightGrid(); }); } return { init: function() { handleEqualHeight(); // initial setup for equal height } } }(); $(document).ready(function() { EqualHeight.init(); }); </script>  <script defer src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-select/1.13.2/js/bootstrap-select.min.js"></script> <script> $('.selectpicker').selectpicker(); </script> <script> $(document).ready(function(){ var filecount = 1; $('.filerowclass').each(function(){ var countattr = $(this).attr('countattr'); if(filecount == countattr){ var countlink = $('#rowfile'+countattr+ ' .filelinkclass').length; if(countlink == 0){ $('#rowfile'+countattr).remove(); } } filecount++; }); }); </script>  <script type="text/javascript"> $(document).ready(function() { $("#wait").hide(); $("#jkeyword").keyup(function() { $("#wait").show(); //values of sending variables var jkeyword=$("#jkeyword").val(); var dataString = { 'jkeyword':jkeyword }; $.ajax ({ type: "POST", url: "https://www.longdom.org/journal-search.php", data: dataString, cache: false, success: function(html) { $("#jresult").html(html); $("#wait").hide(); } }); }); }); </script> <script type="text/javascript">function add_chatinline(){var hccid=98648261;var nt=document.createElement("script");nt.async=true;nt.src="https://mylivechat.com/chatinline.aspx?hccid="+hccid;var ct=document.getElementsByTagName("script")[0];ct.parentNode.insertBefore(nt,ct);} add_chatinline(); </script> <link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/css/select2.min.css" rel="stylesheet" /> <script defer src="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/js/select2.min.js"></script>  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.0/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>  <script language="javascript"> $(document).ready(function(){ //$.noConflict(); $.ajax({ url: "https://www.longdom.org/journals/ajax_getarticle_charges.php", data: { 'jid':'eoed' }, type: 'post', success: function(result){ //var obj = jQuery.parseJSON(result); //$("#articlecharge_usd").html(obj.fee_usd); //$("#articlecharge_euro").html(obj.fee_euro); //$("#articlecharge_gbp").html(obj.fee_gbp); $("#proc_fees").html(result); } }); }); </script> </body> </html>